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1. INTRODUCTION 
So many come to the sickroom thinking of themselves as men of science 
fighting disease and not as healers with a little knowledge helping nature to get a 
sick man well 
- AUKLAND GEDDES  
“Wherever the art of medicine is loved, there is also a love of humanity” 
- HIPPOCRATES 
Curiosity and the human deserve to understand and influence the environment and 
to explain and manipulate phenomena has provided the foundations for developing 
science, philosophy, mythology, religion, anthropology and numerous other fields of 
knowledge. 
Humans initially used to do hunting and fill their craving, later they 
(embarked/hatched) with agriculture, harvested raw materials are started to brewing. 
Later they started to cook it in different ways to increase in taste of food. Increase in taste 
of food decreased the nutrition which need for healthing life and leads to discover many 
types of disease. 
Due to this life span of humans also decreased. 
Nowadays scientists are discovering new diseases due to life style modification 
like change in food habits, living style, sleeping cycle, etc. 
In this generation the most leading disease are Hypertension and Diabetes, soon 
Carcinoma will come to this list. 
Hypertension is often called the “SILENT    KILLER”. Hypertension, also 
known as high or raised blood pressure, is a condition in which the blood vessels have 
persistently raised pressure. Blood is carried from the heart to all parts of the body in the 
vessels. Blood pressure is created by the force of the blood pushing against the wall of 
blood vessels (arteries) as it is pumped by the heart. The highest the pressure the harder 
the heart has to pump
 [1]
. 
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 The word hypertension comes from the prefix “Hyper” meaning “Excessive” and 
the root word “tension” for “force”. Hypertension literally means “excessive force”. 
Blood pressure reading consists of two numbers. The higher number is called “systole” 
and the lower one “diastole”. When the muscles of the heart contract, blood is pumped 
out to the body. 
 The Greek word for contraction is “systole”, thus the pressure generated the heart 
to pump the blood into the circulation is called systolic pressure. The Greek word 
“diastole” means “drawing apart” and is the term used the phase between heart beats 
which the muscle relaxes and the heart fills with blood to the pumped out again. The 
diastolic blood is the pressure in the arteries between beats of the heart. 
 The normal BP was 120mmHg in systole and 80mmHg in diastole. The first stage 
of HBP was 130mmHg in systole and the diastolic becomes 80-89mmHg. The second 
stage ranges from 140 or higher in systolic and 90 of higher in diastolic. One more 
condition called Hypertensive crisis or Hypertensive emergency, in this condition BP 
elevated higher than 180mmHg in systolic and the diastolic pressure becomes higher than 
120mmHg.
[2]
 
Table No 1:  Blood Pressure Levels in Adults 
BLOOD  
PRESSURE  
CATEGORY 
SYSTOLIC 
mmHg 
(upper number) 
DIASTOLIC 
mmHg 
(lower number) 
Normal Less than 120 Less than 80 
Elevated 120-129 Less than 80 
High Blood Pressure 
(Hypertension Stage 1) 
130-139 80-89 
High Blood Pressure 
(Hypertension Stage 2) 
140 or Higher 90 or Higher 
Hypertensive Crisis Higher than 180 Higher than 120 
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Table No 2: Ideal BP According to Age  
AGE FEMALE MALE 
1-2 Years 120/75 mmHg 117/76 mmHg 
5 Years 104/65 mmHg 103/66 mmHg 
10 Years 111/73 mmHg 112/73 mmHg 
15 Years 120/76 mmHg 120/78 mmHg 
19-24 Years 120/79 mmHg 120/79 mmHg 
25-29 Years 120/80 mmHg 121/80 mmHg 
30-35 Years 122/81 mmHg 123/82 mmHg 
50-55 Years 129/85 mmHg 128/85 mmHg 
60+ Years 134/84 mmHg 135/88 mmHg 
 
 There are two types of HT. each type has a different cause. 
i.  Primary HT:  
Also called essential HT. it develops over time with no identifiable cause. Most 
people have this type of HBP. Still unclear what mechanisms cause blood pressure to 
slowly increase. Factors include Gene, Physical changes and Environmental changes.
[3]
 
ii.  Secondary HT:  
It often occurs quickly and can become more severe than primary HT. several 
conditions that may cause secondary HT include Kidney disease, Obstructive sleep 
apnea, Congenital heart defect, problems with Thyroid, side effects of Medication, 
Alcohol, Adrenal gland problems, Endocrine tumors. Some with HBP reports Head ache 
(Particularly at the back of the head and in the morning), as well as light headedness, 
Vertigo, tinnitus (Buzzing or Hissing in the ears), altered vision or fainting episodes.
[4]
 
 These symptoms, however, might be related to associated anxiety rather than the 
HBP itself. Long term HBP, however, is a major risk factor for Coronary artery disease, 
Stroke, Peripheral vascular disease, Vision loss, chronic kidney disease and Dementia.
[5]
 
 High blood pressure is a major public heart problem in India and its prevalence 
rapidly increasing among both urban and rural populations. In fact, HT is the most 
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prevalence chronic disease in India. More than 10 million cases per year. In India, home 
to more than a sixth of a rapid epidemiological transition. Rates of non-communicable 
disease have risen in recent decades and are loely to continue as India’s population ages 
and urbanies.  Meanwhile, many areas of India still face… infectious disease and poor 
maternal and child’s health.  
 The prevalence of HT was 20% among women and 24.5% among men. 
Hypertension in the age group of 18-25 years was 12.1%. The researchers used health 
data collected from 1.3 million adults across India. 
 Hypertension among middle aged adults in the poorest households in rural areas 
was also high 30% had HT. Rates of HT is high among people geographic measures and 
sociodemographic groups in India. 
 The prevalence of HT ranges from 20-40% in urban adults and 12-17% among 
rural adults. The number of people with HT is projected to increase from 1.8 million in 
2000 to 214 million in 2025, with equal numbers of men and women.
[6]
 
 A survey of 26000 adults in south India showed a hypertension prevalence of 
20% (Men 23% Women 17%) but 67% of those with HT were unaware of their 
diagnosis.
[7]
 
 Prevalence of HT in urban is 22-30%. The latest study gives importance as there 
is very little on prevalence of HT in rural Tamilnadu. 
 Hypertension is one of the major risk factors for CVD, Stroke and Kidney failure. 
About 24.5% of deaths in people aged 45-59 years in rural Tamilnadu are caused by 
diseases of the circulatory system problems.
[8]
 
Hypertension management deals not only in reducing the blood pressure but also 
minimize the cardiovascular risk by lifestyle measures, lipid managements, smoking 
cessation, dietary intervention, weight reduction and physical activity. Uncontrolled 
blood pressure can lead to stroke, aneurysm, heart failure, vision loss, metabolic 
syndrome and even memory loss.
[9]
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 A variety of blood pressure lowering medicines (Antihypertensive drugs) is 
available in market. 
1. Angiotensin Converting Enzyme  
2. Angiotensin II receptor blockers 
3. Calcium channel blockers  
4. Diuretics 
5. Beta-blockers  
6. Alpha-blockers  
7. Centrally acting Anti-hypertensive drugs  
8. Vasodilators which reduce BP by dilatation of blood vessels Eg: Hydralazine. 
Adverse effect of these drugs: 
  Dry cough, Dizziness, Taste disturbances and Rashes, Head ache, Dizziness, 
flushed face, Head ache, swollen ankles, Constipation, Dizziness and Tiredness, Urinary 
frequency, Dizziness, Gastro intestinal disturbances, Tiredness, Cold hands and feet, 
Slow heartbeat, Diarrhoea and Nausea, Sleep disturbances, Nightmares, Hypotension 
(notably postural Hypotension), Syncope, Asthenia, and Tachycardia.
[10]
 
India’s ancient vogue and Tamilnadu conventional medicine was that the Siddhars 
devoted Siddha medicine. 
“Natural forces within us are the true healers of disease” 
- HIPPOCRATES 
Siddha means Knowledge. Siddhars are Spiritual scientists. Siddha medicine not only 
cures the physical illness but also for the soul illness. 
Siddha is one of the earliest traditional medicine systems in the world which treats not 
only the body but also the mind and the soul. The word Siddha has its origin in the Tamil 
word Siddhi which means “an object to be attained” or “perfection” or “heavenly bliss”. 
India being the birth place of many traditional philosophies also gave birth to Siddha. The 
roots of this system are intertwined with the culture of ancient Tamil civilization. 
                                                                                            INTRODUCTION 
 
ANTI-HYPERTENSIVE ACTIVITY OF ELADHI CHOORANAM  6 
 
“Siddhargal” or Siddhars were the premier scholars of this system in ancient times, 
Siddhars, mainly hailing from Tamil Nadu laid the foundation for Siddha system of 
medicine. Siddhars were spiritual masters who possessed the asta (eight) Siddhis or 
unique powers. Agasthiyar is believed to be the founding father of siddha medicine. 
Eighteen Siddhars are considered to be pillars of Siddha medicine. Siddha medicine is 
clamied to revitalize and rejuvenate dysfunctional organs that cause the disease. 
Kayakarpam, a special combination of medicine and life style, Varmam theray, Vaasi 
(Pranayamam) and Muppu the universal salt are the specialities of Siddha system of 
medicine. Thus this system connects both spiritual and physical and treats the person as a 
whole i.e. it concentrates the physical, psychological, social and spiritual well-being of an 
individual. 
“Healing is a matter of time, but it is sometimes also a matter of opportunity” 
- HIPPOCRATES 
 According to Siddhars, human body is made up of Pancha boothas (மண், நீர், தீ, 
வளி, வவளி), Three humors (வாதம், பித்தம், கபம்), Seven Udarkatugal (சாரம், வசந்நீர், 
ஊன், வகாழுப்பு, என்பு, மூளை, சுக்கிலம்). 
 ‘The environment is not separate from ourselves.  
We are inside it, and it is inside us.  
We make it, and it makes us.’ 
- YANOMAMI 
 Cosmos energy is present with in the human body also. If there changes in the 
cosmos it also changes in the human body. This well said as 
“அண்டத்தில் உள்ைதத பிண்டம் 
பிண்டத்தில் உள்ைதத அண்டம்” 
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மறுப்பது உடல் த ாய் மருந்வதனலாகும் 
மறுப்பது உை த ாய் மருந்வதனச்சாலும் 
மறுப்பது இனி த ாய் வாராதிருக்க 
மறுப்பது சாளவ மருந்வதனலாதம” 
- திருமந்திரம் 
      
  One that cures physical ailment is medicine 
  One that cures psychological ailments  
  One that prevents ailment is medicine 
  One that bestows immortality is medicine.           
     – ‘‘Thirumandhiram” 
The above verses mean that the medicine should be improve as a curative, 
preventive form and should be significantly improve the quality of life duration said by 
‘Thirumoolar’. That kind of   medicines are found in our system to treat high blood 
pressure but is not scientifically validated. 
            Here to overcome this serious consequence of Hypertension we need 
proper medication and improved quality of life. Hence, in the treatment aspect of Siddha 
system the present investigations decided to choose the polyherbal formulation of Eladhi 
chooranam. I hope this formulation of polyherbal trail drug will be effective in the 
management of hypertension after preclinical validation of Anti-Hypertensive, Diuretic, 
Anti-Oxidant activity. 
 
                                                                         AIM AND OBJECTIVES       
 
 
ANTI-HYPERTENSIVE ACTIVITY OF ELADHI CHOORANAM 8 
 
                                   2. AIM AND OBJECTIVES 
AIM: 
The aim of this study is to validate the Anti-hypertensive, Diuretic and Anti 
-oxidant Activity of Eladhi chooranam and thus ensuring a holistic approach by 
controlling the blood pressure level, significantly decreasing the development and 
progression of complication of Kuruthi Azhal Noi (HT) 
OBJECTIVES: 
 The main objective of the present study is to highlight the safety and 
efficacy of Eladhi chooranam in the treatment of  Kuruthi Azhal Noi, the 
following methodology was adopted to evaluate the drug and standardization 
studies. 
The key objectives of the study are: 
 Collection of various Siddha and modern literature relevant to the study. 
 Preparing the drug according to Siddha classical text. 
 Subjecting the drug into Physico-chemical standardization. 
 Analyzing the drug chemically for detection of acid and basic radicals. 
 Focusing the drug for analytical assessment through sophisticated analytical 
modern techniques like FTIR, ICP-MS, SEM, XRD, GCR. 
 Studying the toxicity profile of Eladhi chooranam   according to OECD 
guidelines. 
 Evaluation of the pharmacological activity of the test drug Eladhi chooranam 
through the following activities,  
             Anti-hypertensive, Diuretic Activities in wistar albino rats  
             Anti- Oxidant activity - Through DPPH assay   
 Evaluation of Microbial load for this formulation. 
 Analyzing all the above study results to evaluate the benefits of Eladhi 
Chooranam   
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                                            3. REVIEW OF LITERATURE  
DRUG REVIEW: 
ELADHI CHOORANAM  
ஏலமில வங்கந்தா மரைநற் பூவி 
 னிதழிலந்ரதக் ககாட்ரையுை  பருப்பும் நல்ல 
ககாலமுய ைல்லிமல ரிதமும் வாசங் 
 குலவுபச்ரசக் கர்ப்பூை முத்தக் காசு 
சீலகநல்லின் கபாரியுமாதி மதுை  கமாப்பாய்ச் 
 கசய்து கபாடி நார்ககாருக  ழஞ்சு கதனில் 
கமலதரைக் கூட்டியுண்ைா லிைத்த பித்த 
 மிதமில்லாப் கபரும்பாடும் வாசி யாகம. 
      (108) 
Ingredients:  
 Elakkai (Elettaria cardamomum) 
 Thamarai poovithaz (Nelumbo nucifera) 
 Allipoo (Nymphaea nouchali) 
 Korai kizhangu (Cyperus rotundus)    
 Athimathuram (Glycyrrhiza glabra)      
 Kirambu (Syzygium aromaticum) 
 Ilanthai kottai paruppu (Ziziphus mauritiania) 
 Pachai karpooram (Dryobalanops aromatica) 
 Nerpori (Oryza sativa) 
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3.1 GUNAPADAM ASPECT OF THE TRIAL DRUG [11]                      
Elakkai (Elettaria cardamomum) 
Other names: Anji, Korangam, Thudi. 
Vernacular names: 
  English : Cardamomum seeds  
  Telugu : Elakulu 
  Malayalam : Elattari      
  Hindi             : Elachi     
  Sanskrit : Ela 
Part used    : Seeds 
Properties:   
 Taste : Acrid 
 Character : Hot 
 Division     : Acrid 
Actions: 
 Carminative  
 Stimulant 
 Stomachic 
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 General character: 
      “கதாண்ரைவாய்கவுள் தாலுகு தங்களில் 
    கதான்றும் கநாயதி சாைம்பன் கமகத்தால் 
    உண்ரை கபால்எழுங் கட்டி கிரிச்சைம் 
  உழரல வாந்தி சிலந்தி விஷஞ்சுைம் 
  
 பண்ரை கவக்ரக விதாககநாய் காசமும் 
  பாழுஞ் கசாமப் பிணிவிந்து நட்ைமும் 
 அண்ரை யீரைவன் பித்தம் இரவக்ககல்லாம் 
  ஆல மாங்கமழ் ஏலமருந்தகத
(11a). 
     -கதைன் குணவாகைம் 
 
   ஏலம் 
   …………………………………………….. 
   ……………………………………புண்ைரிக  
   நாலுதிை மூக்கு நலிககல நாவிகயாடு 
   நாலுதிை மூக்குபத்து நாள்.
(11b)
 
 
Indications: 
 It cures Cough, Dysuria, Dysentery and it increases the sperm count. 
 The powder of E.cardamonum which is used as Akiranam and cures 
epistasis, sinusitis, headache. 
Therapeutic Uses: 
 Ela vadakam used to cure stomach pain, diarrhoea. 
 Ela nei cures thirst, disorders in the stomach and cools the body and increases 
the blood. 
 Decoction of Elam, which cures Thaba suram. 
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                             Thamarai poovithazgal (Nelumbo nucifera ) 
Other names: 
 Raaseevam, Irumbu, Maraipoo, Sooriya natpu, Aravindham, Kamalam, 
Pundarikam, Pathumam,. 
Vernacular names: 
 English         : The sacred Lotus 
 Telugu  : Tamara 
 Malayalam : Aravindam 
 Sanskrit       : Pankaja 
Part used    : Flower, Petals, Seed, Rhizome 
Properties: 
 Taste        : Sweet, Astringent 
 Character: Coolant 
 Division   : Sweet 
Action:  
 Coolant 
 Astringent 
 Expectorant 
 Sedative 
General character: 
பருத்தநற் றாமரைப்பூ பல்வாந்தி கநாரயத் 
துைத்திவிடும் இன்னுஞ் கசால்லகவா-கைத்தில் 
எடுத்தரணக்க்க் கண்குளிரும் ஏகுஞ் சுைமும் 
எடுத்தவி தாகமும்கபாம் எண்.
(11c) 
  -அகத்தியர் குணவாகைம் 
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தாமரைப் பூத்தாள் 
   “சண்ைரையுஞ் சண்ைரையுந் தள்ைமல ருள்ளுரறயுண் 
   சண்ைரையுஞ் சண்ைரலயுஞ் சார்”.
(11d)
 
- கதரையர் யமகம் 
Indications:  
 It cures abdominal pain, Itching, Thirst, Fever, Heart diseases. 
 It cures eye irritation due to body heat. 
Therapeutic uses: 
 Pollen powder of Lotus+Sugar+Honey mixed well and which cures Deafness 
and improves Aphrodisiac activity. 
 
Alli poovithazgal (Nymphaea nouchali) 
Other names: 
  Album, Kumutham, Kairavam. 
Vernacular name: 
English :  Water lilly 
Telugu :  Kalava 
Malayalam :  Allit-tamara 
Sanskrit :  Kumudam 
Hindi   :  Kanava  
Part used    :  Flower, leaf, Rhizome 
Properties: 
Taste  : Astringent 
Character : Coolant 
Division : Sweet 
Actions: 
 Emollient 
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General character: 
      கசவ்வல்லிப் பூவுக்குக் கசர்ந்திறங்கு நீர்ப்பிணிகயா 
கைாவ்வுகம கப்பிணியும் ஓய்வதன்றி-இவ்வுலகிற் 
கண்ணின்கநாய் தீரும் கைத்தபித்த ைத்தகமாடு 
புண்ணின்கநாய்பன்கைாயும் கபாம்.
(11e)
 
                                       -அகத்தியர் குணப்பாைம்.                                                                                 
Indications:     
 It cures Diabetes, Hypertension, Eye disorders due to over body heat, 
Wounds, Venereal disease, Urinary tract infection, thirst, and body 
heat. 
 The leaf decoction used to wash wounds. 
 
                                         Korai kizhangu (Cyperus rotendus) 
Other names: 
  Muthakaasu. 
Vernacular name: 
English          :   Nut grass 
Telugu           :   Tungamuste 
Malayalam    :   Muththanna 
Part used:  Rhizome  
Actions: 
 Diuretic 
 Diaphoretic 
 Emmenagogue 
 Stimulant 
 Tonic 
 Demulcent 
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General character: 
   சீத சுைந்தீர்க்குஞ் கசம்புைல்பித் தம்கபாகும் 
 வாத சுைந்தணிக்கும் ரவயகத்தில்-கவரதகசய்ய 
 வந்த பிணிரயகயல்லாம் வாட்டுமுத் தக்காசு 
 ககாந்துலவும் வார்குழகல! கூறு 
 அதிசாைம் பித்தம் அைற்றாகம் ஐயங் 
 குதிவாதஞ் கசாபங் ககாடிய-முதிர்வாந்தி 
 யாரைத் கதாைர்ந்தாலும் அவ்வ்வர்க்கக லாங்குைத்துக் 
 ககாரைக் கிழாங்ரக ககாடு 
(11f) 
                                                -அகத்தியர் குணவாகைம் 
Indications: 
 It cures Hypertension, Thirst, Delirium and Vomiting.             
 Decoction cures Diarrhoea and Ulcer. 
 While applying the paste externally, it is used to treat scorpion sting 
bite. 
Therapeutic uses: 
  “ககால வுணரவக் குமை ைைலிலடு 
  ககால வுணரவக் ககாடுக யத்ரத” 
(11g) 
 It is used in the treatment of Tuberculosis. 
 Sleeping in Korai mat causes cooling effect in body and sleep. 
                                      Athimaduram  (Glycyrrhiza glabra) 
Other names:  Athingam, atti madhugam, Kundri ver. 
Vernacular names:  
  English         : Jequitity, Indian or Jamaica liquorice 
  Telugu          : Ati-Madhuramu, Yasti-Madhukam   
  Malayalam   : Ati-Madhuram, Iratti-Madhurarr 
  Sanskrit        : Yashti-Madhukam 
  Hindi             : Jathi-Madh, Mulath 
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Part used:  Root 
Properties: 
   Taste           : Sweet 
   Character : coolant 
        Division       : Sweet 
Actions:   
 Emollient 
 Demulcent 
 Expectorant 
 Laxative 
 Tonic 
General character:  
      கத்தியரி முப்பிணியால் வருபுண் தாகங் 
             கண்கணாய் உன்மாதம்விக்கல் வலிகவண் குட்ைம்  
          பித்தகமலும் புருக்கி கிரிச்சைம் ஆவர்த்த  
              பித்தமத மூர்ச்ரச விை பாகம் கவப்பந் 
          தத்திவரு வாதகசா ணிதங்கா மாரல 
    சருவவிைங் காமியகநாய் தாது நட்ைங் 
             குத்திருமல் ஆசியங்கம் இதழ்கநாய் இந்து 
           குயப்புணும்கபாம் மதூககமைக் கூறுங் காகல
(11h)
. 
- கதைன் குணவாகைம். 
Indications: 
 It is also indicated for Jaundice, Arthritis, Eye diseases, Skin diseases, 
Leukoderma and Migraine.  
 Used to cure burning sensation, removes body toxins and cures psychiatric 
diseases. 
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Therapeutic uses: 
 The root of Indian liquorice is chewed for cough. 
 The legium of Indian liquorice cures burning mituration. 
 Indian liquore powder cures head ache, migraine, fever and improves eye site. 
Kirambu (Zysygium aromaticum) 
Other names: 
Anjukam, Urkadam, karuvaai kirambu, Sosam, Thirali, varaankam. 
Vernacular name: 
English :  Clove 
Telugu :  Lavangalu 
Malayalam :  Karampu 
Sanskrit :  Lavangam 
Hindi   :  Long 
Part used:  Leaves, Flower 
Properties: 
Taste  : Sweet, Acrid 
Character : Hot  
Division : Acrid 
Action: 
 Antispasmodic 
 Carminative 
 Stomachic 
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General characters: 
     பித்த மயக்கம் கபதிகயாடு வாந்தியும் கபாம் 
சுத்தவிைத் த்க்கடுப்புந் கதான்றுகமா-கமத்த 
இலவங்கங் ககாண்ைவருக் ககற் சுகமாகும் 
மலமங்கக கட்டுகமை வாழ்த்து. 
சுக்கிலைட் ைங்கர்ண சூர்வியங்க லாஞ்சன்ந்தாட் 
சிக்கல்விைாச் சர்வா சியப்பிணியு-மக்கிக்குட் 
ைங்கப் பூகவாடு தரிபைருந் கதான்றிலி 
வங்கப்பூ கவாடுரைத்து வா 
(11i)
. 
- அகத்தியர் குணவாகைம் 
Uses:  
 It cures prolonged Diarrhoea, Dysentery, Ear diseases and Tinea 
infections.  
 This is used as cooking masala. 
Therapeutic uses: 
 The clove powder decoction stops hyperemesis gravidarum. 
 Increases appetite and promotes digestion. 
 Clove oil Externally act as 
a. Antiseptic 
b. Local anaesthetic 
c. Rubefacient  
 Internally act as 
a. Stomachic 
b. Nutritive 
 Dip the cotton balls in the clove oil and placed it over the upper and 
lower jaw which cures tooth ache. 
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Ilandhai kottai paruppu  (Ziziphus mauritiania) 
Other names: 
  Kullathi, Kulvali, Kol, Korkodi, Vathari. 
Vernacular name: 
English :  The Indian jujube tree, Chinese dale 
Telugu :  Regu 
Malayalam :  Ilanda 
Sanskrit :  Badari; Kola 
Hindi   :  Baer 
Part used:  Leaves, Fruit, Bark, Root, Root barks, Wood, Lentil nut, Whole plant, 
Properties: 
Taste  : Sour, Sweet  
Character : Coolant  
Division : Sweet 
Action: 
 Astringent 
 Emollient 
General Character: 
       ககாண்ரையா மிலந்ரதரயக் ககாள்ைகவத்திறத்திலும் 
மண்டிய கநாகயலா மாய்ந்துகபாய் விடுகம. 
(11j)
 
Indications:  
 It cures Pitha diseases 
 Decoction of leaf and bark cures dysentry and abdominal cramp. 
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Nerpori (Oryza sativa) 
Other names: 
  Thorai, Vai, Viriki, Sen nel, Saali, Vari. 
Vernacular name: 
English :  Paddy 
Telugu :  Vari 
Malayalam :  Nella 
Sanskrit :  Vrihi 
Hindi   :  Chaval 
Part used:  Rice, Bran, Husky 
Properties: 
Taste  : Sweet  
Character : Coolant  
Division : Sweet 
Action: 
 Nutrient 
General Character: 
      கநற்கபாரிரயத் தின்றால் கநடுந்தாகம் வாந்திமந்தம் 
மற்பித்த வாதமத மூர்ச்ரச-பற்பலவாம் 
கபதி யருசியிரவ விட்கைாழியுஞ் 
சாதி மைமயிகல சாற்று 
(11k)
 
- அகத்தியர் குணவாகைம் 
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Indication:  
 It cures abdominal pain, leucorrhoea, burning micturation, fever and gives 
strength to those patients. 
 And also which cures thirst, tastelessness, ascites, indigestion, vomiting. 
Therapeutic uses: 
 Decoction of Nerpori cures prolonged vomiting and ulcer. 
Pachchai karpooram (Drobalanobs aromatica) 
 One among the twenty five type of Karasaaram. 
Other names:  
 Imavalugam, Kathaliuppu, Kelithipachchai, Sasi, Chandran, Somanuppu, 
Seethalam, Mathi, Maruvaali. 
General properties: 
            “அட்ைகுன்மஞ் சூரல யணுகாது வாதகமாடு 
 துட்ைகம கபபிணியுந் கதாற்றாகத - மட்ைலருங் 
 கூந்தலுரை மாகத ககாடியகபம் கபாகுஞ் 
 சார்பச்ரசக் கர்ப்பூைத் தால்.”
 (11l)
 
- அகத்தியர் குணவாகைம் 
Effective in eight types of gastric ulcers, Vatha disease, joint pain and Kapha. 
Action:  
 Expectorant  
 Tonic  
 Demulcent 
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Uses
 
 Scabies, bad odour due to excess sweating.  
 It controls leucorrhoea as an internal medicine. 
 Along with musk gives stimulant action and cures fever due to Kapha Vatha, 
cough, asthma, pulmonary diseases. 
 Mixed with sandal paste and applied over the body for demulcent effect. 
3.2 BOTANICAL ASPECT: 
                                             Elettaria cardamomum 
[12]
 
Taxonomical classification  
Kingdom     : Plantae 
Division       : Magnoliophyta                                 
Class            :  Liliopsida 
Order           : Zingiberales 
Family         : Zingiberaceae 
Genus          : Elettaria 
Species        : cardamomum                                        
Distribution:                                                                      
 Throughout in India. 
Description:  
Stem perennial, erect, joined, 6-9 feet, enveloped in the sheaths of leaves; 
leaves lanceolate, acuminate, sub-sessile, entire, 1-2 feet long; sheaths slightly villous; 
scapes several, flexuose, joined, branched, 1-2 feet long; flowers alternate, short 
stalked, solitary at each point of the raceme; calyx funnel shaped, 3-toothed, inely 
striated,  corolla tube as long as the calyx;  limb doubled exterior portion of 3 oblong,  
concave, nearly equal division; inner lip obovate, longer then the exterior division, 
curled at the marings. 
Elettaria cardamomum 
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Apex 3- lobed, marked in the centre with purple white stripes; capsule oval, 
somewhat 3-sided, 3- celled, 3-valved; seeds numerous, angular; flowers pale-
greenish white. 
Part used: Seeds 
Chemical constituents:  
 α-pinene, β-pinene, sabinene, myecene, a-phyllandrene, limonene; 1,8-cineole, y-
terpinene, p-cymene, terpinolene, linalool, linalyl acetate, terpinen-4-oil, α-terpineol, 
α-terpineol acetate, citronellol, nerol, geraniol, methyl eugenol and trans-nerolidol. 
Properties and Uses: 
As cordial and stimulant the seeds are frequently used medicinally, but more 
frequently as corrective in conjunction with other medicines. A volatile is produced 
from them by distillation, which has a strong aromatic taste, soluble in alcohol. It 
loses its odour and taste by being kept too long. The natives chew the fruit with betle, 
and use it in decoction for bowel-complaints and to check vomiting in infusion it is 
given in cough. 
Nelumbo nucifera 
[13]
 
Taxonomical classification 
Kingdom : Plantae 
Division : Tracheophyta 
Class : Magnoliopsida  
Order : Proteales 
Family : Nelumbonaceae  
Genus : Nelumbo 
Species: nucifera                                                 Nelumbo nucifera  
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Distribution:                                                               
 Throughout in India, in marshes and ponds upto an elevation of 1,800m. 
Description: 
A large handsome aquatic herb with slender elongate, branched, creeping, 
rhizomes sending out roots at the nodes; leaves pelate, 60-90 cm or more in diameter; 
petioles very long, smoother or with small prickles, much raised out of water; flower 
solitary large, fragrant, white or rosy with a centrally located yellow obconical spongy 
tours in which capsules are shrunken; fruits ovoid, nut like achenes. 
Part used: Whole plant 
Chemical constituents: 
Linalool, nonadecane, phytol, raffinose, neferine, nelumbine, liensinine, 
isoliensinine, nuciferine. 
Properties and uses: 
 The plant is astringent, bitter, sweet, cooling, emollient, diuretic, anti-
fungal, anti-pyretic, cardiactonic. It is useful in hyperdipsia, vitiated 
conditions of pitta, cholera, diarrhoea, helminthiasis, vomiting, burning 
sensation, haemorrhoids, nervous exhaustion, ringworm, dermopathy, 
intermittent fever, strangury and cardiac debility. 
 The stem is astringent, cooling, fragrant, diuretic, anthelmintic and useful 
in vomiting, leprosy and skin diseases. 
 The roots are bitter, cooling, emollient, diuretic, and useful in 
pharyngopathy, pectoralgia, spermatorrhea, smallpox, diarrhoea, 
dysentery, cough, vitiated conditions of pitta. 
 The leaves are bitter, cooling, diuretic, and are useful in burning sensation, 
hyperdipsia, fever, strangury, haemorrhoids and leprosy. 
 The flowers are sweet, astringent, refrigerant and cardiac tonic. They are 
useful in diarrhoea, cholera, fever, hepatopathy, hyperdipsia, internal 
injuries, bronchitis, cough, skin eruptions and vitiated conditions of pitta. 
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 The stamens are cooling, astringent, diuretic, aphrodisiac and are useful in 
diarrhoea, hyperdipsia, haemorrhoids, inflammations, stomatitis and 
menorrhagia. 
 The fruits and seeds are bitter, sweet, cooling, diuretic, tonic, depurative 
and aphrodisiac. They are useful in hyperdipsia dermopathy, halitosis, 
burning sensation, vomiting, menorrhagia, leucorrhoea, fever, pectoral 
diseases, leprosy and pruritis.
 
Nymphaea nouchali
[14]
 
Taxonomical classification:                        
Kingdom :  Plantae  
Division : Magnoliophyta 
Class  : Magnoliopsida 
Order  :  Nymphaeles 
Family :  Nymphaeaceae  
Genus  :   Nymphaea 
Species :   nouchali      
Distribution:                                                                          
 Throughout the warmer parts of India, in tanks, ponds and ditches 
Description:  
 A large perennial aquatic herb with short, erect, roundish, tuberous rhizome; 
leaves floating, peltate, sharply sinuate-toothed, flowers large, floating, solitary, 
variable in colour from pure white to deep red; fruits spongy many seeded berries, 
seeds minute, greyish black when dry with longitudinal striations  
Part used: Rhizomes, Flowers, Seeds 
 
 
Nymphaea nouchali 
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Chemical constituents:  
 Apigenin, polysaccharides contain units of L-arabinose, D-xylose and small 
amounts of D-galactose and D-mannose. 
Properties and uses: 
 The rhizome is cooling, sweet, bitter and tonic, and is useful in diarrhoea, 
dysentery, dipsia and general debility. 
 The flowers are astringent and cardio tonic. 
 The seeds are sweet, cooling, constipating, aphrodisiac, stomachic and 
restorative. 
 They are useful in vitiated conditions of pitta, dipsia, diarrhoea and 
dermatopathy. 
                                                      Cyperus rotundus 
Taxonomical classification   
Kingdom       :   Plantae 
Division : Mangnoliphyta 
Class  : Liliopsida  
Order            :  Poales 
Family           :   Cyperaceae 
Genus            :   Cyperus 
Species          :   rotund us 
Distribution:                                                            
 Throughout India, as a weed in waste lands from sea level to 1800m.                                                                                                
 
 
 
Cyperus rotundus 
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Description: 
  A perennial glabrous herb with elongate slender stolons bearing hard black 
fragrant tubers and triquetrous aerial stems; leaves numerous, narrowly linear, finely 
acuminate, flat, one nerved; spikelets in compound expanded umbels, spikelets linear 
to lanceolate, glumes imbricate; nut trigonus, broadly obovoid, greyish black 
Part used: Tubers 
Chemical constituents: 
 Cyperone, myrtenol, caryophyllene oxide, β-pinene, a-pinene, myrtenol, a-
seliene
[15]
 Isorotundene, cypera-2,4 (15)-diene, norrotundene and ketone-cyperadione, 
rotundene
[16]  
carbohydrates, saponin, flavonoid, alkaloid, β cyanins, quinones, 
terpenoids, phenols, coumarins, proteins, steroids  
Properties and Uses: 
 The tubers are bitter, acrid, astringent, cooling, anti-inflammatory, revulsive, 
galactagogue, depurative, intellect promoting, nervine tonic, digestive, 
carminative, anthelmintic, stomachic, constipating, diuretic, lithotriptic, 
expectorant, diaphoretic, Emmenagogue, vulnerary, febrifuge, antiperiodic 
and tonic. 
 Useful in vitiated conditions of Kapha and Pitta, hyperdipsia, inflammations, 
agalactia, leprosy, skin diseases, scabies, erysipcias, pruritis, amentia, 
neurasthenia, epilepsy, anorexia, dyspepsia, flatulence, colic, verminosis, 
diarrhoea, dysentery, strangury, renal and vescical calculi, cough bronchitis, 
amenorrhoea, dysmenorrhoea, wounds, ulcers, fever intermittent and malarial 
fevers, vomiting, ophthalmia and general debility. 
 It is used to treat fever, digestive disorder, dysmenorrhoea and other malaties. 
 It is used to treat skin disease like eczema, scabies and itching. 
 Helps to burn fat deposition in obese people. 
 It is a nerve relaxant and helps to treat diseases like psychosis, epilepsy and 
mental health problems
[17] 
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Glycyrrhiza glabra
[18]
 
Taxonomical classification 
Kingdom   : Plantae 
Division    : Magnoliophyta 
Class : Magnoliopsida 
Order : Fabales 
Family      : Fabaceae 
Genus       : Glycyrrhiza   
Species        :  glabra 
Distribution:                                                                 
 Cultivated in Punjab and the sub Himalayas tract.  
Description: 
A tall perennial under shrub about 1m high, leaves compound, leaflet 4-7 
pairs; flowers violet in racemes; pods, oblong to linear, flattened, seeds reniform. The 
liquorice of commerce in the dried underground stems and roots. 
Its outer surface is pale, chocolate brown in colour, flexible, fibrous and 
internally has a light yellow colour. It has a characteristic pleasant sweet taste. 
Part used: Roots. 
Chemical constituents: 
Glycyrrhizin, glycyrrhetic acid, glycyrrhetinic acid, 24-hydroxy glycyrrhetic 
acid, mixture of potassium and calcium salts of glycyrrhizinic  (glycyrrhizic) acid, 
glabrin A and B,  glycyrrhetol, glabrolide, isoglabrolide, formononetin, glabrone, 
neoliquiritin, hispaglabridin A and B; heriniarin, umbellifrone; licoagrodin, glabrol, 
onocerin, β-amyrin, stigmasterol, β-sitosterol, glabroisoflavanone A and B, 
glabrocoumarin, glychionide A and B and flavanoides. 
 
Glycyrrhiza glabra 
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Properties and uses: 
 The roots are sweet; refrigerant, emetic, tonic, diuretic, demulcent, mild 
laxative, aphrodisiac, expectorant, emmanagogue, alexipharmic, and intellect 
promoting.  
 They are useful in hyperdipsia, cough, bronchitis, vitiated conditions of vatha, 
cephalalgia, fever, skin diseases and opthalmopathy. 
 An extract of the root is good for treating gastric ulcers. A decoction of the 
root is a good wash for falling and graying of hair. Externally the root is 
applied for cuts and wounds.  
 
Syzygium aromaticum
[19]
 
Taxonomical classification 
Kingdom   : Plantae 
Division    : Magnoliophyta 
Class : Magnoliopsida 
Order : Myrtales 
Family      : Myrtaceae 
Genus        : Syzygium  
Species    : aromaticum 
Distribution:  
Cultivated mainly in Tamil Nadu and Kerala 
Description:  
 An evergreen tree, 9-12m high or more. Leaves ovate-oblong, acute at both ends, 
gland-dotted, fragrant. Flower-buds borne in terminal, small clusters of branches, 
greenish; pink at maturity, aromatic. Fruits fleshy, dark pink dupes. Seeds oblong, 
grooved in one side. 
Part used: Dried flower-buds 
   Syzygium aromaticum 
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Chemical constituents:  
 Mainly β-caryophyllene; eugenol and its acetate, methylsalicylate; η-
amylcarbinol, benzyl alcohol, dimethylfurfural, furfuryl alcohol, α-methylfurfural, 
methyl alcohol, methylvenzoate, methylfurfuryl alcohol nethyl-n-hepatylketone, 
methyl-n-hepatylcarbinol, valeraldehyde, vanillin, 2,6-dimethyl-5-hydeozy-7-
methoxychromone (Eugenitine), 2,8-dimethyl-5,7-dihydroxychromone (Isoeugenitol), 
2-methyl-5-hydroxy-7-methoxychromone (Eugenine), 2,4,6-trimethoxybenzoyl 
acetone (Eugenone). 
 From flowers-bud oil of wild cloves; furfual, methyl alcohol, naphthalene (Clove 
stem oil); benzaldehye, carvacrol, α-humulene, methyeugenol, eugenine, eugenone, 
epoxydihydrocaryophylle, methyl-n-amylketone, methyllpentanone, naphthalene 
(Leaf oil); caryophylla-3(12), 6-dien-4-ol, caryophylla-3(12), 7(13)-dien-6 α-al, 
caryophyllene oxide, 2-hydroxy-4,6-dimethoxy-5-methylaceto-phenone (Clove oil); 
galactose, glucose, fructose, rhamnose, csucrose, xylose, gallotannic and oleanolic 
acids are isolated from the cloves 
Properties and uses: 
 Dried flower-buds: Antispasmodic, aromatic, carminative, stimulant 
 Beneficial in colic, dyspepsia, flatulence and various forms of gastric 
irritabsility, sore throat and in strengthening of gum, infusion given to allay 
thirst. 
 Paste applied externally with much benefit in coryza and headache. 
 Employed in Ayurvedic formulations for bronchitis, debility, dyspepsia and 
giddiness. 
 Clove oil is antiseptic, local anesthetic, counter irritant and rubefacient. 
 Externally applied in lumbago, neuralgia, rheumatic pains, sciatica and tooth 
ache. 
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Ziziphus mauritiania
[20]
 
Taxonomical classification 
Kingdom   : Plantae 
Division    :  Tracheophyta 
Class : Magnoliopsida 
Order  : Rosales 
Family       : Rhamnaceae 
Genus         :  Ziziphus  
Species      :  mauritiana 
Distribution:  
Found wild throughout India in waste places or tropical forests and in the 
outer Himalaya upto 1500m. also occurs in Sri Lanka, Malacca, Afghanistan, China, 
Australia, Tropical Africa and Burma 
Description:  
A large thorny shrub or small tree with rough grey or black bark; prickles on 
stems, young branches softly pubescent. Leaves simple, alternate, 2-6 cm long, 
variable, oblong-elliptic, ovate or subobicular, serrate or entire, three nerved, glabrous 
above covered beneath with a dense whitish or buff tomentum, prickles solitary or in 
pairs, 2.5 cm long. Flowers bisexual, greenish-yellow in small axillary clusters or 
short peduncled axillary cymes. Drupes globose or ovoid, succulent, fleshy, smooth, 
yellow or orange when ripe, stone 1-2 celled. Flowering and Fruiting: September--
January 
Part used: Fruit, Stem bark, Leaf, Root, Seed 
 
 
 
 
Ziziphus marutiana 
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Chemical constituents: 
 Plant: Jujuboside D, jujuboside A, 5,7,4’-trihydoxyflavonol-3O-beta-D-
rhamnopyranosyl-(1-&gt;6)-beta-D-glucopyranoside,  phenylalanine, jujuboside E, 
jujuboside B, jujuboside A, betulic acid, surose, inosine. 
 Leaves: Flavanoids, ziziphin, 13C-frangulamine, yuziphine, yuzirin as ®-1-(4’-
hydroxybenzyl)-7-methoxy-8-hydroxy tetrahydrosioguinoline and 1(4’-
hydrozybenzyl)-6-methoxy-7-hydroxyisoghinoline, cocklaurine, isoboldine, 
norisoboldine, asimilobine, n-octacosanol, alphitolic acid and saponin composed of 
abetin lactone, glucose, arabinose, 6 deoxy-L-mlose, ceanothic acid, betulinic acid, 
rutin. 
 Fruit: sapogenin-zizogenin, dammarane sapinin I, II and III, jujuboside B, 
flovone-C-glucosides-6”-sinapoylspinosin, 6”-feruloylspinosin and 6”-p-
coumaroylspinosin, colubrinic acid, alphitolic acid, 3-O-cis-p-coumaroyl-maslinic 
acid, 3-O-trans-p-coumaroylmaslinic acid, betulinic acid, oleanolic acid, betulonic 
acid, zizyberenalic acid, fatty acids, carotenes, frangufoline, a flavonoid-spinosin, 
carbohydrates, fat, protein, amino acids, anthocyanins, leucoanthocyanins, catechins, 
cytokinin like zeatin, cyclic guanosine 3’,5’ monophosphate, carotene, citric, folic and 
malic acids, oleic acid, alphitolic acid, palmitoleic, vaccinic acid, zizyphus-pectin A, 
reducing and non-reducing sugars, niacin, riboflavin, thiamine, vitamin C, vitamin B, 
quercetin, cyclic Amp, jujubosie A,B, berberine, protopine eriodictyol, myricctin 3-O-
glucoside, 3-O-rutinoside, rhamnetin, lauric acid, myristic acid, palmitic acid, 
palmitoleic acid, stearic acid, oleic acid, linoleic acid, arachidic acid, docosanoic acid. 
 Stem bark: Leucocyanidin, leucopelargocyanidin, amphibine-H, jubanies A and 
B, mucronine D and A, hummularines A and B, sapogenins as hecogenin acid, 
cocogenin, chlorogenic acid, mucronine-D, maslinic, usolics, 2α hydroxyursolic acid, 
mauritinen A, B, C, D, E, F, G, jubanine-C, scutianine-C and zizyphine-A. 
 Seed: Jujuboside A and B, 1,3-di-O-[9(Z)-octadecenoyl]-2-O-[9(Z), 12(Z)-
octadecadienoyl]glycerol and a fatty acid mixture of linoleic, oleic and stearic acids, 
3-O-[9(Z)-octadecenoyl]betulinic acid, and betulinic acid, jujuboside A1 and C and 
acetyl jujuboside B, protojujubosides A, B, and B1. 
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Substitutes and Adulterants: 
 There are few varieties of jujube under cultivation and are used as substitute. 
Besides these, fruits of z.oenoplia Mill., Z.xylopyra Wild., Z.rugosa Lam., Z.sativa 
Gae, Z.nummularia W and A , are sometimes used as substitute or adulterants. 
Properties and uses: 
 The ripe fruit is indigestible, aphrodisiac, anodyne, astringent, cooling, 
stomachic, styptic, tonic, expectorant, mild laxative and removes impurities 
from the blood.  
 Leaves and twigs paste applied to abscesses, boils and curbuncles to promote 
suppuration and to strangury.  
 Stem bark astringent, powder or decoction useful in diarrhoea, dysentery and 
in boils.  
 Root bark juice is purgative, externally applied to gout and rheumatism. 
 Decoction of root is beneficial in fever and powder for old wounds and ulcers 
 Seeds are acrid and sweetish, tonic, antidiarrheal. 
 Kernel used for abdominal pain in pregnancy and an antidote to aconite 
poisoning. 
 It is used as antiemetic, sedative, sodorific and also cures eye diseases. 
 Leaves astringent and diaphoretic. 
Dryobalanops aromatica
[21]
 
Taxonomical classification 
Kingdom     : Plantae 
Division       :  Magnoliophyta 
Class          : Magnoliopsida 
Order          : Malvales 
Family         : Dipterocarpaceae 
Genus          :  Dryobalanops 
Species        :  aromatica 
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BORNEO CAMPHOR: 
Distribution: 
 A genus of tall tree, Yielding camphoraceous-oleoresin, distributed in Sumatra 
from bornea. 
Undisturbed mixed dipterocarp forests at elevations up to 300 metres. Usually 
found growing on hillsides and ridges with sandy soils. In secondary forests it is 
usually present as a pre-disturbance remnant tree. 
Description: 
 Borneo Camphor is a tall, evergreen tree with a large, globose crown; it 
usually reaches a height of 40-50 metres, with occasional specimens up to 60 metres 
tall. It has a straight bole that can be un branched for 30 metres and is usually 1-1.5 
metres in diameter with exceptional specimens to 3 metres. 
 The tree is a source of camphor, used medicinally and in perfumes, and is also 
the most important source of a high quality timber, known as kapur, which is used 
locally and also traded.  
 The plant has a long history of medicinal use, with evidence that it has been 
traded internationally since at least the 6
th
 century AD. 
 The tree is classified as critically endangered in the IUCN Red list of 
Threatened Species (2009), with only small subpopulations of the species having been 
found in forest reserves. 
Properties: 
 Borneo camphor is found in cavities or fissures in the wood of D. aromatica 
and is collected by scraping. 
 It occurs in white translucent masses and closely resembles true camphor from 
Cinnamomum camphora in many aspects. 
 It is distinguished by not volatilizing at ordinary temperature and possessing a 
characteristic pungent odour, burning taste. 
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 It is used in same manner as camphor in medicines and perfumery. It is also 
employed in organic synthesis Borneo camphor is highly prized in Indian medicine 
(Wealth of India). 
Chemical constituents: 
 Borneol 
 Camphene 
 Terpeniol 
 Sesquiterpene 
Chemically, Borneo camphor is almost pure d-borneol.it is converted into 
ordinary camphor by treatment with boiling nitric acid. 
Oryza sativa 
[22]
 
Taxonomical classification 
Kingdom     : Plantae 
Division       :  Magnoliophyta 
Class          : Liliopdida 
Order          : Poales 
Family         : Poaceae 
Genus          :  Oryza 
Species        :  sativa 
Distribution:  
Throughout India, cultivated. 
Description:   
An annual or perennial grass with tuft of fibrous roots and swollen nodes; 
leaves simple with sheathing bases, long and narrow, slightly pubescent with spiny 
hairs on the margins; flowers spikelets in terminal compound panicles, lemma 
punctate of granulate without wing on the back, lemma and palea surrounding the 
 
Oryza sativa 
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kernel, golden yellow, reddish purple, brown or smoky black becoming straw-colored 
on ripening, grains narrowly oblong, free within the lemma and palea. 
Part used: Roots, Grains 
Chemical constituents:  
Carlinoside, flavonoid pigments, glucotricin, oryzalexin A, B and C, alanine, 
arginine, aspartic acid, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, 
methionine, phenylalanine, proline, serine, threonine, tyrosine, valine, 
triaceylglycerols, acylated steryl glucoside, phosphatidylcholine, 
phosphatidylethanolamine, phosphatidylinositol, phosphatidic acid, stachydrine, 
trigonelline, stigmastanol, starch, glucose, detrin, fructose, galactose, raffinose, 
maltose, arabinose and xylose, mannose, uronic acid, a glutelin as oryzenin, albumin, 
α and β globulins and prolamines, tryptophan, phenylalanine, xanthine, adenine, 
hypoxanthine, ammonia, vitamins E and B, pantothenic acid, pyridoxine, enzymes 
like α amylase, β amylase, amylosynhease, lipase, phenolase. 
Properties and uses:  
 The roots are cooling, diuretic and febrifuge. Useful in burning sensation, 
dispepsia, bilious fever, strangury and diabetes. 
 The grains are sweet, acrid, oleaginous, aphrodisiac, diuretic, carminative, 
antidysenteric and tonic. 
 They are useful in vitiated conditions of Pitta, pneumonosis especially 
pulmonary consumption, diarrhoea and clolnopathy. 
 Seeds with milk beneficial in peptic ulcer, powder dusted over surface has a 
cooling and soothing effect on burns and scald. 
 It is beneficial in erysipelas, measles, pox, prickly heat and other inflammatory 
affections of the skin. 
 As poultice applied to abscess, boils, buboes, inflammatory affections, piles 
and ulcers also to chest in chronic bronchitis and cough. 
 Rice-water used in febrile and intestinal disorders as demulcent, refrigerant 
and soothing.  
 Rice gruel useful in impaired digestion like diarrhoea and dysentery.  
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3.3 LITERATURE REVIEW OF DISEASE 
3.3.1 SIDDHA ASPECT OF THE DISEASE 
KURUTHI AZHAL NOI: 
Definition: 
It refers to the functional divergence in seneer thathu (blood), produced as a 
results of increased azhal (bio energy fire) eventully leading to consequent functional 
dearrangements in other udal thathus. 
Vernacular names: 
“இரத்த வமுக்கத் தியரப்ெய ருரரத்திடிற் 
இரத்தாதிக்கம் யழுத்தம் இரத்தக் பகாதிெ்பு 
நந்திடும் நாடிஇறுக்கமும் நவில்வர ்
ெத்திடுங் காரணம் ெகரக்ககண்கமா” 
-கநாய்நாடல் கநாய்முதல் நாடல்திரடட்ு
[23] 
 Raktha soodu, Raktha azhutham, Raktha miguthi, Raktha perukkam, 
Rakthathikkam, Narambirukkam and Naadi irukkam. 
Types of Disease: 
 The disease may be classified into eight types as follows: 
                    1. Vali kuruthiazhal noi 
               2. Thee kuruthiazhal noi 
                    3. Iya kuruthiazhal noi 
                    4. Vali thee kuruthiazhal noi 
                    5. Vali iya kuruthiazhal noi 
                    6. Iya vali kuruthiazhal noi 
                    7. Iya azhal kuruthiazhal noi 
                    8. Mukkutra kuruthiazhal noi 
 
 Some other groups of ancient physicians have classified this disease into four 
types depending upon the direction of flow of blood as follows: 
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                    1. Maelnokku kuruthiazhal noi 
                    2. Keelnokku kuruthiazhal noi 
                    3. Irunokku kuruthiazhal noi 
                    4. Alavilla nokku kuruthiazhal noi
[24] 
Clinical features: 
 Head ache most commonly seen in occipital region, dizziness, 
palpitation, easy fatigability, weakness. 
 Dysponea, chest pain, pallor, perspiration, vertigo, syncope. 
 Epistaxis, heamaturia, blurring of vision. 
Epidemiology: 
“ககட்டிடு ென்னாடப்கடு மலசச்ிக்கல் 
கூட்டிடும்மதுக் கள்பகாள்ளல் புரகயிரல 
நாட்டிடும் மாவரக நற்பகாழுெ்பிரறசச்ி 
ஊடட்ுதல் மிகுதல் ஊரைெ்புமிகுதி 
மிகுமனக்களிெ்பு மிகுநாடித்துடிெ்பு 
தரு மனகவாட்டம் நாடுதல்காமம் 
தருகமககநாயிகள் தக்க ெல்பதாண்ரட 
ெகு பித்தெ்ரெ ெலஉறுெ்பினிலும்” 
    -கநாய்நாடல் கநாய்முதல் நாடல்திரடட்ு
 
Kuruthi azhal noi is high in urban population and more common in men than 
women. In females the prevalence is closely related to age. This is increased 
presumeably related to the menopause. 
 
 The elavenil (early summer),  muthuvenil (late summer) aggressive the 
disease. 
 Paalai (arid-tract) and neithal (coastal-tract) reported compared to other 
areas
[23a]
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3.3.2 MODERN ASPECT OF THE DISEASE 
HYPERTENSION 
The history of hypertension starts at 1628 when the book De Motu Cadrdis 
was published, and the book was written by an English physician Willium Harvey, 
who described the circulation of blood. Then the elergyman Stephen hales made the 
first measurement of blood pressure in 1733. Hypertension was described as a disease 
by thomus young and Richard in 1836. In 1884 the first report of  elevated blood 
pressure in a person without evidence of kidney disease was recorded. Eventually in 
1896 the invention cuff-based sphygmomanometer done by Scipione Riva-Rocci. 
Then the blood pressure was measured in the clinics, Nikolai korotkoff improved this 
technique by describing the korkoff sounds. These sounds are heard when the artery 
was ascultated with a stethoscope while the sphygmomanometer cuff was deflated. 
Now in modern medicine, hypertension is classified into two type’s essential 
and secondary hypertension. The concept of essential hypertension was introduced in 
1925 by the physiologist Otto frank, which has idiopathic origin. In 1928 the term 
malignant hypertension was coined by physicians from the mayo clinic. The essential 
hypertension may be the result of a combination of poor life style choices and 
genetics. Secondary hypertension that starts as a result of another disease especially 
kidney disease or disease associated with endocrine system
 [25]
 
Definition: 
Systemic hypertension is the persistent rise of basal blood pressure above the 
level of 140/90mmHg recorded on three or more successive occasions
 [26]
. 
Classification of hypertension 
 Essential or idiopathic hypertension  
 Secondary or symptomatic hypertension 
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Table 3: Classification of blood pressure for adult (JNC7)
 [27]
 
 
Category Systolic mmHg Diastolic mmHg 
Normal 90-119 60-79 
High normal 
(pre-hypertension) 
120-139 80-89 
Stage I 
Hypertension 
140-159 90-99 
Stage II 
(Hypertension) 
160-179 100-109 
Stage III 
(Hypertensive emergency) 
≥ 180 ≥ 110 
Isolated Hypertension ≥ 140 < 90 
                                         
White coat Hypertension 
It is commonly known as white coat syndrome or masked hypertension, is a 
phenomenon in which patient exhibit a blood pressure level above normal range, In a 
clinical setting, though they don’t having exhibit other it in other settings. It is 
believed that the phenomenon is due to anxiety that those afflicted experience during 
a clinical visit
 [28]
. 
Pathophysiology of Hypertension 
Blood pressure is determined by the balance between cardiac output and 
vascular resistance rise in either of these variables, in the absence of a compensatory 
decrease in the other, increases mean Bp, which is the driving pressure. 
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Factors that affect cardiac output include the following: 
 Baroreceptors 
 Extracellular volume 
 Effective circulating volume, Arterial natriuretic hormones, 
Mineralocorticoids, Angiotensin 
 Sympathetic nervous syndrome 
Factors that affect vascular resistance include the following: 
 Depressors-angiotensin II, calcium (intracellular), catecholamines, 
vasopressin. 
 Depressors-Artial natri uretic hormones, endothelial relaxing factors, 
kinins, prostaglandin, prostaglandin E2, prostaglandin I2 
Changes in the electrolyte homeostasis particularly in sodium, calcium and 
potassium concentrations, affect some of these factors. 
Under normal conditions, the amount of sodium excreted in the urine matches 
the amount of ingested, resulting in near constancy of extracellular volume. Retention 
of sodium results in increased extracellular volume, which associated with elevation 
of Bp. By means of various physical and hormonal mechanisms, elevation triggers 
changes in both the glomerular filtration rate (GFR) and the tubular reabsorption of 
sodium, resulting in excretion of excess sodium and restoration of sodium balance. 
A rise in the intracellular calcium concentration, due to changes in plasma 
calcium concentration, increases vascular contractility. In addition, calcium stimulates 
release of renin, synthesis of epinephrine and sympathetic nervous system activity. 
Increased potassium intake suppresses the production and release of renin and induces 
natriuresis, decreasing the Bp.  
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Table 4: Common causes of hypertension by age
29
 
Infants Children 1-6 yrs Children 7-12 
Thrombosis of renal artery 
or vein 
Renal artery stenosis Renal parenchymal disease 
Congenital renal 
anomalies 
Renal parenchymal disease Renovascular 
abnormalities 
Coarctation of aorta Wilms tumor 
Neuroblastoma 
Endocrine causes 
Bronchopulmonary 
dysplasia 
Coarctation of aorta Essential hypertension 
 
Causes of primary hypertension: 
Also commonly known essential hypertension, is a disorder which is 
associated with elevated blood pressure whose causes are not readily identifiable. Its 
prevalence tends to rise with age in most populations. Essential hypertension is 
common in adults. 
The following risk factors for primary hypertension: 
 Obesity or being overweight 
 Excessive salt consumption 
 Family history and genetics 
 Sedentary life style[30]  
Causes for secondary hypertension 
 Renal causes- acute nephritic syndrome, chronic nephritis, Poly cystic kidney, 
Hydronephrosis, chronic pyelonephritis, Renal artery stenosis, Renin secreting 
tumour, Renal embolism. 
 Endocrine causes- thyrotoxicosis and myxoedema, acromegaly, cushing’s 
syndrome, cohn’s syndrome, pheochromocytoma. 
 Metabolic causes- diabetes mellitus, chronic gout, toxemias of pregnancy, 
atherosclerosis. 
 Drugs- contraceptive pills, steroids, liquorice. 
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 Collagenosis and miscellaneous disease- SLE, polyarteritis nodosa, 
scleroderma, dermatomyositis, pseudoxanthoma elasticum. 
 Congenital- coarctation of aorta. 
 Psychogenic 
 Neurological- encephalitis, brain tumour, cerebro vascular accident, 
diencephalic Syndrome. 
 Blood disease- Polycythemia 
 Renovascular hypertension-  particularly in renal artery stenosis 
 Miscellaneous- Pregnancy, Cyclosporine, NSAIDs.[30] 
Clinical features: 
 Pulsating head ache often in occipital and occurs particularly in the morning. 
 Easy fatiguability 
 Insomnia 
 Dizziness 
 Lack of concentration 
 Loss of memory 
 Occational palpitation 
Symptoms of associated disease may also present e.g. Cerebral 
Arteriosclerosis, Retinal Arteriosclerosis, Coronary Arteriosclerosis, Renal 
arteriosclerosis and Arteriosclerosis of limb of vessels
 [31]
. 
Complication: 
Cardiac hypertensive heart disease 
Left Ventricular Hypertrophy develops in 10-30% of chronic cases. It may 
produce myocardial ischemia, ventricular arrhythmia, CCF and sudden death; LV 
diastolic dysfunction may also develop with CCF. 
Cerebral 
Cerebro vascular complications are more closely to systolic rather than 
diastolic blood pressure. 
 Cerebral hemorrhages 
 Cerebral thrombosis 
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 Lacunars infarct 
 Hypertensive encephalopathy- this condition is acute cerebral ischemia from 
Hypertensive spasm, Cerebral edema and minor degree of hemorrhages or 
thrombosis. 
 TIA- transient ischemic attack 
 Subarachnoid hemorrhages. 
 Dementia- both vascular and Alzheimer’s type 
Retinal  
 Dimness of vision 
 Thickening of arteries with Narrowing of lumen, Hemorrhage. 
 Papilloedema. 
 Detachment of Retina, Vitreous Hemorrhages. 
Renal 
 Patients with hypertensive nephropathy should have BP at 130/85mmHg or less if 
proteinuria is present. Hypertension accelerates all forms of renal disease mostly 
diabetic nephropathy. 
 Nephrosclerosis 
 Uremia 
 Renal infarct 
Aortic dissection 
 The major cause of hypertension. 
Atherosclerotic complications 
Many patients of hypertension die out of these complication but the 
relationship is much less close than other complications. 
 Cerebral arteriosclerosis 
 Retinal arteriosclerosis 
 Coronary arteriosclerosis 
 Renal arteriosclerosis 
 Arteriosclerosis of limb vessels. 
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Pregnancy induced hypertension 
Gestational hypertension also referred to pregnancy induced hypertension 
(PIH). It is a condition of high blood pressure more than 140/90mmHg on two 
separate occasions, more than 6 hours apart, without the presence of protein in the 
urine during pregnancy. It is diagnosed after 20 weeks of gestation. Gestational 
hypertension can lead to serious condition called pre-eclampsia
[32]
. 
Hypertensive crisis 
In some situations in hypertensive patients rapid reduction of blood pressure is 
required. These situations are including under the category of hypertensive crisis. 
These situations divided into two.    
  1. Hypertensive urgencies 
Where blood pressure reduction is required comparatively slowly, Diastolic 
pressure is more than 130mmHg. 
2. Hypertensive emergencies (Malignant hypertension)  
Where immediate (within one hour) reduction of blood pressure is required. 
Systolic blood pressure is greater than 210mmHg of diastolic blood pressure 
130mmHg. 
Clinical features include  
 Headache 
 Confusion 
 Visual loss 
 Focal Neurologic features 
 Somnolence 
 Coma 
 Fundus shows Hemorrhages, Exudates and Papilloedema. 
Mode of termination 
 Acute left ventricular failure (60%) 
 Cerebral hemorrhages (35%) 
 Uremia rare(5%)[33] 
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Differential diagnosis:  
 Aortic coarctation: 
 Differential blood pressure in upper and lower extremities. Absent of femoral 
pulses. 
Obstructive sleep apnea: 
 Typically obese patients with day time somnolence, snoring, or choking during 
sleep
 [34]
.
 
Investigations: 
 Urine analysis, Protein and Glucose 
 Blood, Urea, Electrolytes and creatinine 
 Blood glucose 
 Serum total and high-density lipoprotein(HDL) Cholesterol 
 12-lead ECG (left ventricular Hypertrophy, Coronary artery disease) 
 Endocrine: Serum Sodium, Potassium, Calcium and TSH[33a] 
3.4 TREATMENT FOR HYPERTENSION  
3.4.1 SIDDHA ASPECT 
In siddha system the treatment for Kuruthi azhal noi is based on the 
normalizing the altered hypertension. 
Vanthi and kazhichal maruthuvam 
(Bowel cleansing method for azhal and vayu thathu) 
 Meganatha thylam-8-30ml at early morning 
 Vellai ennai-15-30 ml at early morning 
 Karuda kizhangu thylam-15 ml at early morning 
 Sanjeevi mathirai-1-2 at early morning with goat’s milk(50ml) kudineer 
 Kowshikar kuzhambu-125-500 mg with ghee at early morning 
 Thiratchai kudineer-40-80ml twice a day 
The choices of medicine, doses and duration may be altered according to the 
condition of the patients and severity of the disease. 
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Chooranam 
 Marutham pattai chooranam-1-2 g twice a day with hotwater(50ml) 
 Ceeraga chooranam-1-2 g twice a day with hotwater(50ml) 
 Thirachathy chooranam-1-2g twice a day with honey(5ml) 
 Seenthil chooranam-1-2g twice a day with ghee(5ml) 
 Thirippala chooranam-1-2g twice a day with hotwater(50ml) 
 Thalisathy chooranam-1-2g twice a day with honey (5ml) 
 Elathy chooranam   1-2g twice a day with warm water(50ml) 
 Amukkara chooranam1-2g twice a day with milk(50ml) 
Nei 
 Brahmi nei 10-15ml twice a day with milk(50ml) 
Manappagu 
 Thurunchi manappagu 15ml twice a day with luke warm water (50ml) 
 Nannari manappagu    15ml twice a day with luke warm water (50ml) 
 Madhulai manappagu  10-15 ml twice a day with luke warm water(50ml) 
Ilagam 
 Thetran ilagam     5-10g twice a day 
 Vilvathy ilagam    5-10g twice a day 
 Madhulai manappagu 3g twice a day 
Karpam  
 Bavana kadukkai (500mg) 1 before and after food twice day 
Parpam 
 Silasathu parpam  300-600mgtwice a day with hotwater(50ml) 
 Kungiliya parpam 100-300mg twice a day tendercoconut water(50ml) 
 Sangu parpam       100-300mg twice a day with ghee(5ml) 
 Nathai parpam      65-130mg twice a day with ghee(5ml) 
 Siringi parpam      65-130mgtwice a day with brahmi nei(10ml) 
Chenduram  
 Vediannabethi chenduram  100-200mg twice a day with honey(5ml) 
 Aya chenduram                   65-130mg twice a day with honey(5ml) 
 Ayakandha chenduram       65-130mg twice a day with honey(5ml)  
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Karpa marunthugal 
Pothu karpam 
 Kattrazhai karpam for 4 days 
 Ponnangani karpam for 4 days  
 Kaiyan karpam 1-2gms for 2 months 
Sirappu karpam 
 Kadukkai karpam   1-2 gms with hotwater at evening for 48 days 
 Panai ver kudinner  60ml twice a day for 48 days 
 Vilva karpam for  48 days 
 Elumitchai pazha karpam for 48 days 
 Orilai thamarai karpam with ghee for 48 days. 
External medicines 
Oil bath may be advised twice a week with any of the following medicated oil. 
 Kaiyan thylam 
 Ceeraga thylam 
 Keezhaneli thylam 
 Lahusandhanathy thylam 
 Arakku thylam 
 Thirippala thylam 
Pathiyam(diet) 
Diet to be added 
 Rice kanji-double boiled rice, savvarisi kanji, pori kanji, barley kanji, 
manakkathai, kuruvai rice. 
 Vegetables- athi, avarai, kathari, vazhai, vendai, murungai, sundai, mullangi, 
pagal, sambal poosani, thoothuvalai, pirandai. 
 Greens- puliyarai, manathakkali, ponnangani, kaiyan, sukkan, vasalai keerai, 
pasalai keerai. 
 Pulses- ulunthu, pasipayaru 
 Dairy products- cow’s butter milk 
 Non-vegetarian diet- ayrai meen (loach), velladu (capea hircus) 
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Diet to be avoided  
 Intake of excessive salt, oil, fried food. 
 Excessive hot, sour and salt tastes. 
 Sarkkarai valli kizhangu (Ipomoea batatas), Seppankizhangu 
(Colacasiaesculanta), Kothavarai (Cyamopsis tetragonoloba), Kollu 
(Macrotylorum uvifiorum), Verkadalai (Arachis hypogea), Kaaramani (Vigna 
ungiculata), Pattani (Pisum sativum), Motchai (lablab purpureus). 
Other instructions 
 Avoid smoking and alcohol intake 
 Dietary management  
 Regular physical activity (brisk walking) at least 30 min/day 
 Weight reduction, maintain normal body weight 
 Relief of stress. 
 Rejuvenation therapy  
Karpayogam 
 Pranayamam 
 Singasanam 
 Sarvangasanam 
 Puyangasanam 
3.4.2TREATMENT FOR HYPERTENSION IN MODERN ASPECT 
Table 5: Classification of Anti-Hypertensive Drugs 
S.NO TYPES OF DRUG NAME OF THE DRUG 
1. ACE inhibitors Captopril 
Enalapril 
Lisinopril 
Ramipril 
2. Angiotensin antagonist Losartan  
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3. Calcium channel blockers Nifidepine 
Felodipine 
Amlodipine 
Verapamil 
Diltiazem 
4. Diuretics Hydrochlorothiazide 
Fruosemide 
Indapamide 
Spironolactone 
Triamterene 
Amiloride 
5. β-adrenergic blockers Propranolol 
Atenolol 
Metaprolol 
6. α-adrenergic blockers Prazocin 
Terazocin 
Phentolamine 
7. Central sympatholytics Clonidine 
Methyldopa 
8. Vasodilators 
(i)Arteriolar 
 
 
(ii)Arteriolar and venular 
  Hydralazine 
Minoxidil 
Diazoxide 
Sodium  
        nitroprusside 
Pinacidil 
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Anti-hypertensive drugs act by influencing the Blood pressure regulatory 
systems viz, the autonomic nervous system, Renin Angoitensin System. Calcium 
channels or sodium and water balance in plasma volume
 [35]
. 
Classification of anti-hypertensive drugs 
Diuretics 
Diuretics lower the blood pressure by increasing urination. The anti-
hypertensive action of diuretics is mild BP falls by 15-20mmHg over 2-4 weeks. 
Diuretics enhance the excretion of sodium and water resulting in decreased 
plasma volume of CO and reduce BP.
 
 Thiazides (Hydrochlorothiazide, Chlorothiazide, Indapamide) 
 Loop diuretics (Fruosemide, Bumetanide, Torsemide) 
 K+  (Spiranolactone, Amiloride, Trimterene) 
Drugs acts on Rennin Angiotensin System 
 Angiotensin converting enzyme inhibitors (ACE inhibitors) (Captopril, 
Enalapril, Lisinopril, Ramipril, Perindopril) 
 Angiotensin II receptor antagonists (Losartan, Candesartan, Valsartan, 
Eprosartan, Irbesartan, Olmesartan) 
 Rennin inhibitor(Aliskien) 
 ACE inhibitors are presently the first line anti-hypertensive. ACE 
inhibitors are useful in the treatment hypertension of all grades due to all 
causes. They are specially indicated as Anti-hypertensives in hypertension 
with left ventricular hypertrophy. 
 Angiotensin II is powerful vasoconstrictor. ARBs are used in the treatment 
of hypertension in similar indications as that of ACE inhibitors as 
alternatives of ACE inhibitors, they can also be considered as the first line 
drug in hypertension. 
 Rennin inhibitors blocks the effects of rennin there by reducing blood 
pressure. Use of several drugs like ACE inhibitors, ARBs and diuretics 
tend to bring about a compensatory rise in the plasma rennin levels. 
Because aliskiren blocks the effects of rennin, its action is synergistic with 
these drugs. 
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Sympatholytics 
 Centrally acting drugs (Clodine, Methyldopa, Guanfacine) 
 Ganglion blockers (Trimethaphan) 
 Adrenergic receptor blockers (Guanethidine, Reserpine) 
 Adrenergic receptor blockers 
 α-blockers  (Prazosin, Terazosin, Doxazosin, Phenoxybenzamine, 
Phentolamine) 
 β-blockers (Propranolol, Atenolol, metoprolol) 
 α and β blockers (Labetalol, Carvedilol). 
Sympatholytics drugs may be used to interfere with sympathetic activity at 
different levels including centrally, at the ganglia, neurons and receptors. 
Ganglion blockers block both sympathetic and parasympathetic ganglia 
resulting in decreased sympathetic tone and a fall in BP. 
Adrenergic receptor blockers depletes the stores of nor adrenaline in the 
adrenergic neurons blockers its release. 
α-blockers are used in the treatment of hypertension due to 
Pheochromacytoma. They block the α1 receptors in the arterioles and venules and 
thereby dilate both arteriole and venules. Peripheral vascular resistance is decreased 
leading to fall in BP with only mild tachycardia. β-blockers are mild anti-
hypertensives. Blockage of β1 receptors results in decreased myocardial contractility 
and cardiac output. Thus they reduce BP due to a fall in the cardiac output 
[36]
. 
Ca+ channel blockers 
CCBs are another important group of anti-hypertensive. They are particularly 
used in elderly patients. CCBs may be used as mono therapy or in moderate to severe 
Hypertension along with other hypertensives (Nifedipine, Nicardipine, Nimodipine, 
Amlodipine, Felodipine, Verpamil). 
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Vasodilators 
 Arteriolar dilators (Hydralazine, Minoxidil, Diazoxide) 
 Arteriolar and venular dilators (sodium nitroprusside) 
  Vasodilators relax the vascular smooth muscle thus reducing BP due to 
decresed peripheral vascular resistance. Nitroprusside is the drug of choice in 
hypertensive emergencies. It is used in situations where short-term reduction of 
myocardial work load is required as serve heart failure and myocardial infarction. 
Adverse effects of anti-hypertensive drugs 
 Angiotensin receptor blockers cause Hypotensin and Hyperkalaemia. 
 Sympatholytics like Methyldopa cause dryness of mouth and nose, depression, 
vertigo, extra-pyramidal signs, raised prolactin levels, postural hypertension. 
 Vasodilators like Hydralazine cause headache, dizziness, flushing, palpitation, 
nausea, anorexia, hypotension and salt and water retension. 
  Sodium nitroprusside cause palpitation, sweating, weakness, nausea, vomiting 
and hypotension
 [37]
.  
Future vaccine:  
                                                       DNA vaccine 
               DNA vaccine that targets angiotensin II- a hormone that raises blood 
pressure by causing blood vessels to constrict. The narrowing can increases blood 
pressure and force heart to work harder. 
             In the study, researchers immunized hypertensive rats three times at two-week 
intervals with needless injections. The vaccine not only lowered blood pressure for up 
to six months, but also reduced tissue damage to the heart and blood vessels 
associated with hypertension. There were no signs of damage to other organs such as 
the kidney or liver. 
  The DNA vaccine works similar to common ACE inhibitor blood pressure 
medications which help blood vessels relax and open up, which in turn lowers blood 
pressure. 
            Other type of vaccine: Peptide vaccine
 [38]
. 
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3.5 PHARMACOLOGICAL REVIEW 
PHARMACOLOGY STUDY OF ANTIHYPERTENSIVE ACTIVITY IN 
ANIMAL MODELS 
HYPERTENSION MODELS 
IN-VITRO MODEL 
 Endothelin receptor antagonism in porcine isolated hearts 
 Monocrotaline induced pulmonary hypertension 
Endothelin Receptor model 
Endothelins (ET) have been implicated in the pathophysiology of 
cardiovascular diseases. In this model isolated porcine coronary artery is used since 
the smooth musculature of artery is considered to contain the ETA receptors. ET 
results in potent long lasting contractions of isolated blood vessel strips. An increase 
of blood pressure in vitro studies has been elicited by Endothelin peptides. 
Monocrotaline-induced pulmonary hypertension 
 Monocrotaline is a hepatotoxic pneumotoxic agent used in Rats for 
pulmonary hypertension. It is a pyrolizidine alkaloid derived from Crotalaria 
spectabilis and single injection leads to progressive pulmonary hypertension followed 
by right ventricular hypertrophy and cardiac failure. Ultrastructural changes such as 
degeneration and fragmentation of endothelial cells and mascularization of pulmonary 
arteries, arterioles are also observed. Monocrotaline administration of rats can results 
in severe right ventricular hypertrophy accompanied by rats and pleural effusion. 
IN-VIVO MODELS 
 RAT MODELS 
I. Reno-vascular induced 
 Two-kidney one clip method (Goldblatt hypertension, 2K1C) 
 Chronic renal hypertension in rats (1-kidney-1-clip method) 
 Chronic renal hypertension in rats (Two kidney two clip method) 
II. Neurogenic induced 
 Blood pressure in pithed  rats 
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           III. Diet induced 
 Fructose induced 
 Increased salt induced 
IV. Endocrine induced 
 DOCA-salt rats 
V. Psychogenic  
 Air-jet stimulation induced hypertension 
VI. Genetically induced 
 Salt-sensitive Dahl rats 
 Spontaneously hypertensive rats 
DOG MODEL OF HYPERTENSION 
 Chronic renal hypertension 
 Neurogenic hypertension 
MONKEY MODEL OF HYPERTENSION 
 Renin inhibition in monkeys 
TRANSGENIC MODEL OF HYPERTENSION  
 Transgenic rats overexpressing the mouse Ren-2 gene [TGR(mRen 2)27] 
Two kidney one clip (Gold blatt hypertension2k1c) 
Sprague dawley rats used for this model 
Ischemia of the kidney causes elevation of blood pressure by activation of 
rennin angiotensin system. In rats clamping the renal artery for 4 hours can activates 
peripheral RAAS and sympathetic nervous system and induce renal hypertension. 
After reopening the vessel, accumulated rennin is released into circulation leading to 
acute hypertension. Renin is secreted by the kidneys when sympathetic activity is 
increased. Renin converts Angiotensin to Angiotensin I, angiotensin II is a potent 
vasoconstrictor and increase blood pressure. Angiotensin II also causes release of 
aldosterone leading to salt and water retention result in increased blood volume and 
hypertension. This model is used to evaluate anti-hypertensive activities of drugs. 
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Chronic renal hypertension (one kidney one clip method) 
The one kidney one clip method is the technique has been described for 
several animal species. The most effective modifications in rats in which one kidney 
is removed. Constriction of one kidney is done on one side and the contralateral 
kidney is removed. There is an increase in blood pressure within few hours. Since 
there is no other kidney, there is no blood pressure, diuresis, natriuresis, so there is 
rapid salt and water retention. Plasma renin activity is usually normal hypertension 
soon becames volume dependent. 
Blood pressure in pithed rats 
Male wistar rats (250-350 gms) are used in this model 
The pithed rat model is divided for neurogenic reflex control that may 
modulate the primary drug effect. It is frequently used to evaluate drug action on the 
cardiovascular system. 
Salt-sensitive Dahl rats 
The kidneys have the ability to excrete easily the daily salt load without 
allowing a marked rise in extracellular volume. Chronic ingestion of excess salt 
produces hypertension in rats, which mimics human hypertension. The salt-sensitive 
dahl develop severe and fatal hypertension when feed high salt diets. This is the 
model of genetic hypertension, with the extra feature of Salt sensitive. 
Fructose induced hypertension in rats 
Feeding a high fructose diet induces hypertension and insulin resistance in 
Sprague dawley rats. Fructose feeding also causes insulin resistance, 
hyperinsulinemia and hypertriglyceridemia in normal rats. Fructose feeding induces 
hypertension in normal or high salt feed animals and it is associated with an increased 
expression of the Angiotensin II type I receptor in adipose tissue. AT 1 receptor play a 
role in the pathophysiology of metabolic and hemodynamic abnormalities induced b 
fructose feeding. 
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DOCA-salt rats 
Mineralocorticoids induces hypertension by causing in increased plasma and 
exracellular volume. The administration of deoxycorticosterone acetate (DOCA) , a 
mineralocorticoid in combination with high salt diet and unilateral nephrectomy 
induces hypertension. There is increased DOCA induced reabsorption of salt and 
water leading to increased blood volume and hence increased blood pressure
 [39]
. 
Spontaneously hypertensive rats 
By breeding strain of spontaneous hypertensive wistar rats with a female 
having slightly raised blood pressure, Okamoto and Aoki obtained a strain of rats 
spontaneous hypertension, Spontaneous Hypertension was devopled by meticulous 
genetic in breeding that uniformly resulted in 100% of progeny having naturally 
occurring hypertension. Several researchers reported that the spontaneous 
hypertension is an excellent model of experimental hypertension as well as model for 
complication of hypertension
 [40]
. 
Transgenic rats overexpressing the mouse Ren2 gene [TGR(mRen2)27] 
The ability to specifically introduce genetic constructs and thereby breed 
transgenic animal has opened new possibilities for hypertension research.Recently a 
transgenic rat has been obtained after introduction of the entire mouse Ren 2d gene. 
The introduction and over expression of mouse Ren2  in this rat leads to severe, lethal 
in the homozygous rat. 
Method for the measurement of blood pressure in rats 
 Tail-cuff method in rats 
 Indwelling catheter for measurement of blood pressure in conscious rats. 
Tail cuff method for measuring Bp 
The indirect tail cuff method allows the measurement of Bp without any 
surgical procedure. The principle used in this method is that the pulse obliterate when 
the cuff is inflated will above suspected systolic blood pressure. The pulse reappears 
as the pressure in the cuff is slowly released and it falls below the systolic blood 
pressure. The method is analogous to sphygmonometry in humans. 
The indirect tail cuff method is widely used to evaluate the influence of anti-
hypertensive drugs in spontaneously and experimentally induced hypertensive rats. 
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Indwelling catheter method 
This method allows directly measurement of blood pressure in conscious rat. 
The influence of anesthesia on the cardiovascular regulation is eliminated by this 
method. 
7 cm long cannulae are prepared by cutting pe 10 and pe 20 tubing 
respectively. A style wire is inserted into the pe10 tubing is also slipped over the style 
wire. The tube ends are heated in a current of hot air and fused together. Using ridges 
the style wire is left inside the cannula and the cannula is heated in a jet of hot air. 
When the polyethelene at the point of heating becomes soft, the cannula is pressed 
slightly and the ridges are formed. 
Dog models of hypertension 
 Chronic renal hypertension 
 Neurogenic hypertension 
Chronic renal hypertension 
Partial constriction of renal arteries in dogs produces hypertension. This 
method is modified and is now known as the wrapping technique, a sheet of 
cellophane is placed around the kidney and held in place by silk sutures tied loosely 
around the renal hilus.  Both kidneys are wrapped or one kidney is wrapped and other 
is removed. A fibro collagenous shell is formed around the kidney in 3-5 days 
because of reaction of the tissue to the foreign material. This shell compresses renal 
vascular pressure. This expands the extracellular volume leading to increased 
peripheral resistance and hence increased blood pressure. 
Neurogenic hypertension  
Baroreceptor situated in the carotid sinus and aortic arch play an important 
part in the regulation of blood pressure. Stimulation of baroreceptor causes inhibition 
of vasomotor center leading to vasodilatation, bradycardia and decrease in blood 
pressure. Sectioning of the baroreceptor nerves leads to persistant raise in blood 
pressure. Thus these produce acute neurogenic hypertension in dogs.  
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Renin inhibition method in monkey 
 Blood pressure is mainly regulated by the renin Angiotensin system 
and can be influenced by the inhibition of renin. Renin inhibitors developed for have a 
high specifically for primate rennin and cause only weak inhibition of renin sub 
primate species. It suggests that most commonly laboratory animals such as dog are 
not suitable for in-vivo evaluvation of rennin inhibitor. Marmosets (callithrix jacchus) 
of 300-400 gare feed pellet diet supplemented with fruits. These animals were used 
for rennin inhibition method
 [41]
. 
ANIMAL MODEL FOR THE DISSERTATION 
SPONTANEOUSLY HYPERTENSIVE RATS: 
Systolic blood pressure (SBP) and heart rate measurement of SH rats was 
carried out using tail-cuff method plethysmography (LE 5001 Pressure Meter). A 
mean of six measurements was obtained for each animal. For blood pressure 
measurement, the animals were warmed up to 42°C for 5 min in a confinement cage. 
The animals were first submitted to a period of adaptation for 15 days before the 
experiments and only SHR with an SBP > 170mmHg were selected for this study.  
 During the final week of the treatment, the rats were allowed to acclimatize to the 
experimental conditions of non-invasive SBP measurements by allowing them to 
stand in rat restrainers for 30 min every day. SBP measurements were recorded 24 
hours after the last treatment dose. At least 8-10 recordings were taken for each rat 
and the mean of the lowest 4 values within less than 10 mmHg difference was taken 
as the mean SBP. 
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3.6 PHARMACEUTICAL REVIEW 
CHOORANAM  
Definition: 
Chooranam is a fine powder of drugs. The “Chooranam” may be applied to the 
powders of a single drug or a mixture of two or more drugs, which are powdered 
separately prior to their being mixed to homogeneity
 [42]
. 
Method of preparation: 
Equipment required 
 The drug enumerated in the recipe in clean and well dried state. 
 A mortar and pestle. 
 A fine sieve or fine cloth of close mesh. 
Process of preparation: 
The drugs which are to be used in the preparations should be taken from 
recently collected material. Drugs which are aged by prolonged storages or changed 
in colour, taste and scent, and those that are insects infested or attacked by fungi 
should be positively rejected. 
              However drugs like Embelia fruits, Senna, Long Pepper, Jaggery and cows 
ghee are preferred from fairly aged stock, provided they are not infested with pests, 
deteriorated or spoiled or developed racidity. 
              In general the aromatic drugs are slightly fried in order to enhance their 
aroma and milling properties. Any extraneous material, organic or inorganic, should 
be removed from the drugs by close inspection. 
                                                   The chooranam should be so fine to be called amorphous and should never be 
damp. The fineness of the sieve should be 100 mesh or still finer. 
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Purification of the prepared chooranam: 
“தாபனன்ற சூரணத்தின் சுத்திக்ககளு 
தெ்ொகத சரக்பகல்லாஞ் சூரணித்து 
நாபனன்ற வாவின்ொலாற் பிரசந்து 
நலமான சட்டியிகல ொரலவிடட்ு 
வாபனன்ற சுத்தசலம் ொதிவிடட்ு 
வளமாக கமற்சீரல ககாடுகட்டிெ் 
ொபனன்ற சூரணத்ரதெ் பிடட்ுகொல் ரவது 
ெதறாகத பவந்பதடுக்க்ச ்சித்தியகம!” 
    -அகஸ்தியர ்ரவத்திய இரத்தினசச்ுருக்கம்
[43] 
  The prepared chooranam is mixed with the milk in pot half quantity milk and 
half a quantity water is taken. The mouth of the pot is covered with a thin cloth 
material. Above this cloth the mixed chooranam is placed. The pot is placed over the 
stove and heated. 
“ஆமெ்ொ ரவியுலரத்்திெ்பொடி தான்பசய்து 
அெ்ெகன சமனாய்ச ்சரக்்கரரரயசக்சரத்்து 
நாமெ்ொ பகாண்டுவர கதாஷம்கொசச்ு 
நன்றாக்ச ்சுத்திபசய்யாச ்சூரணந்தான் 
தாமெ்ொ கராகத்ரத பவல்லாதெ்ொ 
தளமான வியதிபயல்லாம் ொரிக்கும்ொர ்
கவமெ்ொ சுத்திபசய்து பகாண்டாயனால் 
பவகுசுறுக்காய் தீருமா வியாதிககளு” 
-அகஸ்தியர ்ரவத்திய இரத்தினசச்ுருக்கம் 
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  Then the chooranam is placed in the sunlight and powdered. All type of 
diseases gets cured. If the drug is taken without purification, the disease does not 
cure. If taken after purification the disease cures easily. 
Storage: 
The prepared chooranam should be allowed to cool by spreading and mixing, 
prior to packing. They should be stored in tightly stoppered glass, polythene or tin 
containers, or in polythene or cellophane bags and sealed. These bags should in turn 
be enclosed in cupboard boxes. 
  
The chooranam to facilitate easy handling and to assure exact dosage 
administration, could be pressed into tablets, could be packed in bottles or tubes made 
either of glass or plastic or packed in strip of metal foil or plastic sheets. 
In industry the tablets are made, counted and packed by electronic devices. 
Then chooranam is said to retain its potency for 3 months and then gradually 
deteriorate. However if properly packed and stored, they keep good for a year. 
(Formulary of Siddha Medicines, 1993)
[42a] 
 According to AYUSH guidelines shelf life of chooranam is one year.
[44]
 
Table 6:  ANALYTICAL SPECIFICATIONS OF CURNA/CHOORNAM 
Sl.No TESTS 
1. 
 
2. 
3. 
4. 
5. 
6. 
7. 
 
8. 
 
Description 
Macroscopic, Microscopic 
Loss on drying at 105˚ C 
Total – ash 
Acid – insoluble ash 
Water-soluble extractive 
Alcohol – soluble extractive 
Particle size (80-100 mesh for Churna; 40-60 
mesh  for churna) 
Identifications,HPLC-withmarker(wherever possible) 
Test for heavy/Toxic metals 
                                                                                                   REVIEW OF LITERATURE 
 
ANTI-HYPERTENSIVE ACTIVITY OF ELADHI CHOORANAM  63 
 
 
                                      
3.7 .LATERAL RESEARCH 
1. Elettaria cardamomum: 
Anti-ulcerogenic activity of Elettaria cardamomum  
 The gastro protective action of petroleum ether soluble fractions and essential 
oils of E.cardamomum is due to increase in gastric motility and it has inhibitory effect 
in over production of some products of 5-lipoxygenase pathway
 [45]
. 
Anti-convulsant activity: 
 The methanolic extract of E.cardamomum against chemically 
(pentylentetrazole) and electrically (maximal electric shock) induced seizures in mice. 
Various pharmacological activities Anti -inflammatory, Analgesic, Anti -oxidant, 
Anti- microbial effects
 [46]
. 
9. 
 
 
 
 
10. 
 
 
11. 
 
 
 
 
12. 
 
 
 
 
Lead 
Cadmium 
Mercury 
Arsenic 
Microbial contamination 
Total bacterial count 
Total fungal count 
Test for specific Pathogen 
E. coli 
Salmonella spp. 
S.aureus 
Pseudomonas aeruginosa 
Pesticide residue 
Organochlorine pesticides 
Organophosphorus pesticides 
Pyrethroids 
Test for Aflatoxins (B1,B2,G1,G2) 
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2. Nelumbo nucifera: 
 Cardioprotective effect of Nelumbo nucifera flower extract against isoproterinol 
induced oxidative stress in male albino Swiss rats 
The present study investigates the cardioprotective effect of Nelumbo nucifera 
flower in isoproterinol induced rats. The positive hypertrophy response of 
isoproterinol caused a severe oxidative stress in the myocardium through increased 
lipid peroxidation. Nelumbo nucifera was administered intra peritonealy at a dose of 
200mg/kg for a period of 30days.
[47] 
Psycopharmacological activity: 
 Methanolic extract of rhizomes of Nelumbo nucifera was investigated for different 
psychopharmacological action in rats and mice. The extract was found to cause 
reduction in spontaneous activity, decrease in exploratory behavioral pattern by the 
head dip and Y-maze test, reduction in the muscle relaxant activity by rotarod 30
0 
inclined screen and traction test and potentiated the pentobarbitone induced sleeping 
time in mice significantly
[47a]
. 
3. Nymphaea nouchali 
 Nymphaea nouchali possesses Antibacterial, Anti-proliferative, Anti-
microbial, Anti-Diabetic also been studied 
[48]
. 
4. Cyperus rotundus 
  Anti-diabetic activity of hydroethsnolic extract of Cyperus rotundus in alloxon 
induced diabetic rats. 
 In right of the traditional claim of Cyperus rotundus in the treatment of diabetes, 
investigations were carried out to evaluate its effect on alloxan induced 
hyperglycemia in rats. Oral daily administration of 500 mg/kg of the extract (once a 
day for seven consecutive days) significantly lowered the blood glucose levels
 [48]
. 
5. Syzygium aromaticum 
  Syzygium aromaticum possesess inhibitory activity against oral pathogens, 
Anti-oxidant property, anti-fungal, Immediate hypersensitivity in rats, Antimutagenic 
activity, Cytotoxicity to human skin cells, Fungicidal activity also been studied
[49]
. 
 
 
                                                                                                   REVIEW OF LITERATURE 
 
ANTI-HYPERTENSIVE ACTIVITY OF ELADHI CHOORANAM  65 
 
6. Ziziphus mauritiana 
  Protective effect of Ziziphus mauritiana leaf extract on carbon tetrachloride- 
induced liver injury. 
  Pretreatment of rats with 200 and 300 mg/kg body wt of Z.mauritiana leaf 
extract protected rats against carbon tetrachloride liver injury by significantly 
lowering aspartate aminotransaminase (AST), alanine aminotransamine (ALT), 
alkaline phosphatase (ALP), total bilirubin (TB), and lipid peroxide levels compared 
to control
 [50]
.  
 
7. Glycyrrhiza glabra: 
  Glycyrrhiza glabra possesses Anti-bacterial, Anti -oxidant, Anti -malarial, 
Anti spasmodic, Anti -inflammatory, Anti hyperglycemic properties. Various other 
effects like ulcer, Anti-viral, Hepatotoxic, and   Anti- fungal have also been studied
 
[51]
. 
Memory enhancing activity: 
 The dose of 150 mg/kg of the aqueous extract of liquorice significantly improved 
learning and memory of mice
 [52]
. 
8. Oryza sativa 
 Application of brassinosteroids to seeds on growth, pigment levels and nitrate 
reductase activity of rice (Oryza sativa L) plants grown on saline substratum was 
investigated. Brassinosteroids reduced the impact of salt stress on growth, 
considerabley restored pigment levels and increased of nitrate reductase activity
 [53]
.  
 Anti-oxidant activity, Scavenging of reactive oxygen species in NaCl-stressed 
rice, Influence of N and Ni supply on nitrogen metabolism and urease activity in rice 
also been studied. 
9. Dryobalanops aromatica 
  Nematicidal and ovicidal activity, Genetic diversity, Hepatoprotective activity, 
Inhibition of acetylcholine-mediated effects by borneol, Inhibitory activities of 
polyphenols, Synthesis and cytotoxic activity of 3, 4, 11-triydroxyl modified 
derivatives of begenin also been studied
 [49a]
. 
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                                 4. MATERIALS AND METHODS 
4.1 Drug selections  
In this dissertation purified and prepared “Eladhi chooranam” was taken as a 
trial drug for Anti-Hypertensive activity from the Siddha Literature “Sarabenthirar 
Vaithya Muraigal ”authored by Dr.S.Venkatarajan (L.I.M)[54] 
Table 7: Ingredients of Eladhi Chooranam: 
S.NO TAMIL NAME BOTANICAL NAME PART USED 
1. Elakkai Elettaria cardamomum Seeds 
2. Thamarai poovithaz Nelumbo nucifera Dried Flower 
3. Allipoo Nymphaea nouchali Dried Flower 
4. Korai kizhangu Cyperus rotendus Rhizome 
5. Adhimathuram Glycyrrhiza glabra Root 
6. Kirambu Syzygium aromaticum Flower 
7. Ilanthai kottai paruppu Ziziphus mauritiania Seed 
8. Pachai karpooram Dryobalanops aromatica Supliment 
9. Nerpori Oryza sativa Fried paddy 
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Quantity of Ingredients: 
 Elakkai (Elettaria cardamomum) 
 Thamarai poovithaz (Nelumbo nucifera) 
 Allipoo (Nymphaea nouchali) 
 Korai kizhangu (Cyperus rotundus)    
 Athimathuram (Glycyrrhiza glabra)    Equal ratio 
 Kirambu (Syzygium aromaticum) 
 Ilanthai kottai paruppu (Ziziphus mauritiania) 
 Pachai karpooram (Dryobalanops aromatica) 
 Nerpori (Oryza sativa) 
 
Collection of the Plant materials 
 The raw materials of Elettaria cardamomum, Dry Cyperus rotundus ,  
Glycyrrhiza glabra root, Syzygium aromaticum, Dry Ziziphus mauritiania, 
Dryobalanops aromatica  and Oryza sativa were collected from the raw 
drug country shop at Parrys corner, Chennai, Tamilnadu. 
 The Petals of Lotus were collected at Sriperumbudur. 
 The Petals of Lilly were collected at Kancheepuram. 
Identification and Authentication of the drug 
All the plant materials were identified and authenticated by the Gunapadam 
experts in Government Siddha Medical College, Arumbakkam, and Chennai – 106. 
The specimen sample of all the herbs have been preserved in PG Gunapadam 
department individually for future reference. 
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Purification of the drugs 
All the drugs mentioned here were purified as per the Siddha literature. 
[55] 
Elakkai: 
            Fried at low flame. 
Korai kizhangu: 
 Impurities are removed and fried at low flame. 
 Adhimdhuram: 
            The root of Indian liquorice was cleaned with water and cut into small                          
pieces and then dried. 
Kirambu: 
 Fried at low flame. 
Ilanthai kottai paruppu: 
 Impurities are removed and the outer shell was breaked off. 
Pachai karpooram: 
 Impurities are removed. 
Nerpori: 
 Impurities are removed. 
Thamarai Poo Ithalkal: 
  Impurities are removed and dried in cool dark place. 
Allipoo: 
Impurities are removed and dried in cool dark place. 
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Preparation of the Drug 
Procedure 
All the above-mentioned ingredients were purified and dried in the shade until 
complete evaporation of the moisture content. It was roasted and powdered and 
filtered individually. (Fine process). Then all are thoroughly mixed to make Eladhi 
Chooranam and kept in an air tight container. It was labelled as “Eladhi 
Chooranam” (EC). 
Purification of the chooranam: 
  Steaming process (Pittaviyalmurai) 
The Eladhi Chooranam was purified by pittaviyal method (steam cooking in 
milk) as per Siddha classical literature. A mud pot was taken and it was half filled by 
mixture of milk with equal quantity of water. The mouth of the pot was sealed by a 
cloth. This chooranam was placed over the cloth and tied firmly around the mouth of 
mud pot by another pot. The gap between mud pots was tied with a wet cloth to avoid 
evaporation. The mud pot was kept on fire and boiled until the cow’s milk 3/4 
reduced in the lower pot. The same drug was later dried and powdered then sieved 
again. It was used for the further study 
[56]
. 
Storage of the drug 
The prepared test drug was stored in a clean, air tight glass container. The 
contents were inspected frequently to avoid moisture and insects. 
Administration of the drug 
Form of the medicine    : Chooranam 
Route of Administration: Enteral 
Dose                               : 5.1 g twice a day 
Vehicle                          : Honey 
Indications                     :        Kuruthi Azhal Noi (Hypertension) 
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Ingredients of Eladhi Chooranam: 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Elakkai 
Elettaria cardamomum 
Fig no 1.3 
Thamarai poovithaz 
Nelumbo nucifera 
Fig no 1.1 
Allipoo 
Nymphaea nouchali 
Fig no 1.4 
 
Korai kizhangu 
Cyperus rotendus 
Fig no 1.2 
Adhimathuram 
Glycyrrhiza glabra 
Fig no 1.5 
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Kirambu 
Syzygium aromaticum 
Fig no 1.6 
Ilanthai kottai paruppu 
Ziziphus mauritiania 
Fig no 1.7 
Pachai karpooram 
Dryobalanops aromatic 
Fig no 1.8 
 
Nerpori 
Oryza sativa 
Fig no 1.9 
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Procedures of Eladhi Chooranam 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Eladhi Chooranam 
      Fig no 2.3 
 
Sieving Eladhi Chooranam  
Fig no 2.2 
Pounding of Eladhi Chooranam 
Fig no 2.1 
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4.2 STANDARDIZATION OF THE DRUG 
Standardization of the drug brings the validation to be used as a medicine by 
subjecting the drug to many analysis and determining its quality and effectiveness. 
Standardization includes many studies such as its organoleptic properties, physical 
characteristics and phytochemical properties and also to assess the active principles 
and elements present in the drug. Thus, standardization brings the efficacy and 
potency of the drug. 
4.2.1 ORGANOLEPTIC CHARACTER 
 The organoleptic characters of the sample drug were evaluated.1gm of 
the test drug was taken and the colour, odour, taste, texture, particle size and other 
morphology were viewed by naked eye under sunlight. Then the result was noted 
[57]
. 
4.2.2 PHYSICOCHEMICAL ANALYSIS 
  Physico  chemical investigations like Solubility, pH value, Loss on drying at 
105°C, and Ash test have been done at The Tamilnadu Dr M.G.R Medical University, 
Anna salai, Guindy, as per the guide lines of WHO 
[58]
. 
Solubility: 
A pinch of sample (EC) was taken in a dry test tube and to it 2 ml of the 
solvent was added and shaken well for about a minute and the results are observed. 
The test was done for solvents like distilled water, Ethanol, Petroleum ether, 
Propylene glycol, Toluene, Benzene, Chloroform, Ethyl alcohol, Xylene, Carbon tetra 
chloride and the results are observed individually.    
pH value:  
Potentiometrically, pH value is determined by a glass electrode and a suitable 
pH meter. The pH of the EC was written in results column.  
Loss On Drying: 
An accurately weighed 1g of Eladhi Chooranam formulation was taken in a 
tarred glass bottle. The crude drug was heated at 105
0
C for 6 hours in an oven till a 
constant weight. The Percentage moisture content of the sample was calculated with 
reference to the shade dried material. 
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Determination of total ash: 
Weighed accurately 2g of Eladhi Chooranam formulation was added in 
crucible at a temperature 600
0
C in a muffle furnace till carbon free ash was obtained. 
It was calculated with reference to the air dried drug.  
Determination of acid insoluble ash: 
Ash above obtained, was boiled for 5min with 25ml of 1M Hydrochloric acid 
and filtered using an ash less filter paper. Insoluble matter retained on filter paper was 
washed with hot water and filter paper was burnt to a constant weight in a muffle 
furnace. The percentage of acid insoluble as was calculated with reference to the air 
dried drug. 
Determination of water soluble ash: 
Total ash 1g was boiled for 5min with 25ml water and insoluble matter 
collected on an ash less filter paper was washed with hot water and ignited for 15min 
at a temperature not exceeding 450
0
C in a muffle furnace. The amount of soluble ash 
is determined by drying the filtrate.  
Determination of water soluble Extractive: 
5gm of air dried drug, coarsely powered Eladhi chooranam was macerated 
with 100ml of distilled water in a closed flask for twenty-four hours shaking 
frequently. The Solution was filtered and 25 ml of filtrated was evaporated in a tarred 
flat bottom shallow dish, further dried at 100
0
 C and weighted. The percentage of 
water soluble extractive was calculated with reference to the air dried drugs.   
Determination of alcohol soluble extractive: 
1 gm of air dried drugs, coarsely powdered Eladhi chooranam was macerated 
with 20 ml. alcohol in closed flask for 24 hrs with frequent shaking. It was filtered 
rapidly taking precaution against loss of alcohol. 10ml of filtrate was then evaporated 
in a tarred flat bottom shallow dish, dried at 100
0
C and weighted. The percentage of 
alcohol soluble extractive was calculated with reference to air dried drug. 
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4.2.3 PHYTOCHEMICAL ANALYSIS 
The Phytochemical screening of the extract gives general idea regarding the 
nature of chemical constituents present in the crude drug. The phytochemical tests 
were done as the method illustrated in 
[59]
. 
1. Detection of alkaloids: 
Extracts were dissolved individually in dilute Hydrochloric acid and filtered. 
a) Dragendroff’s Test: Filtrates were treated with Dragendroff’s reagent 
(solution of Potassium Bismuth Iodide). Formation of red precipitate indicates 
the presence of alkaloids. 
2. Detection of carbohydrates: 
Extracts were dissolved individually in 5 ml distilled water and filtered. The 
filtrates were used to test for the presence of carbohydrates. 
a) Benedict’s Test: Filtrates were treated with Benedict’s reagent and heated 
gently. Orange red precipitate indicates the presence of reducing sugars. 
3. Detection of glycosides:  
Extracts were hydrolyzed with dil. HCl, and then subjected to test for glycosides. 
a) Cardiac glycoside (Keller-Killiani test): Extract was shaken with distilled 
water (5 mL). To this, glacial acetic acid (2 mL) containing a few drops of 
ferric chloride was added, followed by H2SO4 (1 mL) along the side of the 
test tube. The formation of brown ring at the interface gives positive 
indication for cardiac glycoside and a violet ring may appear below the brown 
ring. 
4. Detection of saponins 
a) Froth Test: Extracts were diluted with distilled water to 20ml and this was 
shaken in a graduated cylinder for 15 minutes. Formation of 1 cm layer of 
foam indicates the presence of saponins. 
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5. Detection of phenols Ferric Chloride Test: 
Extracts were treated with 3-4 drops of ferric chloride solution. Formation of 
bluish black colour indicates the presence of phenols. 
6. Detection of tannins Gelatin Test: 
The extract is dissolved in 5 ml of distilled water and 2 ml of 1% solution of 
Gelatin containing 10% NaCl is added to it. White precipitate indicates the presence 
of phenolic compounds. 
7. Detection of Flavonoids 
a) Alkaline Reagent Test: Extracts were treated with few drops of 
sodiumhydroxide solution. Formation of intense yellow color, which becomes 
colorless on addition of dilute acid, indicates the presence of flavonoids. 
8. Detection of proteins  
a) Xanthoprotein Test: The extracts were treated with few drops of conc. 
Nitric acid. Formation of yellow color indicates the presence of proteins. 
9. Detection of aminoacids 
a) Ninhydrin Test:To the extract, 0.25% w/v ninhydrin reagent was added 
and boiled for few minutes. Formation of blue color indicates the presence of 
amino acid. 
10. Detection of diterpenes Copper Acetate Test: 
Extracts were dissolved in water and treated with 3-4 drops of copper acetate 
solution. Formation of emerald green color indicates the presence of diterpenes.  
11. Gum and Mucilage: 
To 1ml of extract add 2.5ml of absolute alcohol and stirring constantly. Then 
the precipitate was dried in air and examine for its swelling properties. Swelling was 
observed that will indicate presence of gum and mucilage. 
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12. Test for Quinones 
Extract was treated with sodium hydroxide blue or red precipitate indicates 
the presence of Quinones. 
13. Test for Fixed oils and Fats 
a. Spot test: A small quantity of extract is pressed between two filter papers. 
Oil stain on the paper indicates the presence of fixed oils. 
HPLC - High Performance Liquid Chromatography (HPLC) 
[60] 
HPLC is a technique in analytical chemistry which is used to separate the 
components in a mixture, to identify each component, and to quantify each 
component. It relies on pumps to pass a pressurized liquid solvent containing the 
sample mixture through a column filled with a solid adsorbent material. Each 
component in the sample interacts slightly differently with the adsorbent material, 
causing different flow rates for the different components and leading to the separation 
of the components as they flow out of the column. In this study, the detection and 
quantitation were carried out using 515 HPLC pumps and 2489 UV/Visible detectors 
of Waters Company while the software used was Empower.  
Two methods using different mobile phases were used for chromatographic 
separation of the research drugs – Method I (binary gradient method of Acetonitrile & 
0.1% Phosphoric acid in Water) and Method II (binary gradient method of Methanol 
& 1:25 Acetic acid in Water). Results obtained during Method I have been discussed 
since better separation of compounds was observed during this analysis. The 
chromatographic conditions for Method I are as given below:  
Column : Symmetry C18, 5µm, 4.6x250 mm   
 Run Time  : 30 minutes 
 Injection Volume : 20 µl 
 Wavelength (Dual) : 272 nm & 360 nm  
Solvent A  : Acetonitrile  
Solvent B  : 0.1% Phosphoric acid in water 
 Flow rate  : 1.0 ml/min. 
 Pump Mode  : Gradient  
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4.2.4 BIO-CHEMICAL ANALYSIS 
Preliminary Basic and Acidic radical studies 
[61] 
Preparation of extract 
 5gm of EC was taken in a 250 ml of clean beaker and 50 ml of distilled water 
was added to it. Then it was boiled well for about 10 minutes. Then it was allowed to 
cool and filtered in a 100 ml volumetric flask and made up to 100 ml with distilled 
water. This preparation was used for the qualitative analysis of acidic/ basic radicals 
and biochemical constituents in it. 
Test for Basic radicals 
1. Test for Potassium 
To a pinch of the EC, 2 ml of sodium nitrate and 2 ml of cobalt nitrate 
solution in 30% glacial acetic acid was added and observed for the presence of yellow 
precipitate. 
2. Test for Calcium 
To 2 ml of EC extract, 2 ml of 4% ammonium oxide solution was added and 
observed for the formation of white precipitate. 
3. Test for Magnesium: 
To 2ml of EC extract, drops of sodium hydroxide solution was added and 
watched for the appearance of white precipitate. 
4. Test for Ammonium: 
To 2ml of EC extract few ml of Nessler's reagent and excess of sodium 
hydroxide solution are added for the appearance of brown colour. 
5. Test for Sodium 
Hydrochloric acid was added with a pinch of the EC, made as paste and 
introduced into the blue flame of Bunsen burner and observed for the appearance of 
intense yellow colour. 
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6. Test for Iron (Ferrous) 
The EC extract was treated with Conc. HNO3 and ammonium thiocyanate and 
waited for the appearance of blood red colour.   
7. Test for Zinc 
To 2 ml of the EC extract drops of sodium hydroxide solution was added and 
observed for white precipitate formation.  
8. Test for Aluminium 
To the 2m1 of the EC extract sodium hydroxide was added in drops and 
changes are noted.  
9. Test for Lead 
To 2 ml of EC extract 2ml of potassium iodide solution was added and noted 
for yellow coloured precipitate.  
10. Test for Copper 
a. A pinch of EC was made into a paste with con. Hcl in a watch glass and 
introduced into the non-luminous part of the flame and noted for blue colour 
appearance. 
b. To 2 ml of EC extract excess of ammonia solution was added and observed 
for the appearance of blue coloured precipitate.  
11. Test for Mercury 
To 2m1 of the EC extract sodium hydroxide solution was added and noted for 
yellow precipitate formation.  
12. Test for Arsenic   
To 2 ml of the EC extract 2ml of sodium hydroxide solution was added and 
brown or red precipitate formation was noted.  
Test for acid radicals 
1. Test for Sulphate 
To   2 ml of the EC extract 5% of barium chloride solution was added and 
observed for the appearance of white precipitate.  
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2. Test for Chloride 
The EC extract was treated with silver nitrate solution and observed for the 
appearance of white precipitate. 
3. Test for Phosphate 
The EC extract was treated with ammonium molybdate and conc. HNO3 and 
observed for the appearance of yellow precipitate. 
4. Test for Carbonate 
The EC extract was treated with conc.Hcl and observed froth appearance of 
effervescence indicate the presence of carbonate. 
5. Test for Fluoride & Oxalate: 
To 2ml of EC extract 2ml of dil.acetic acid and 2ml calcium chloride solution 
was added and heated and watched for cloudy appearance. 
6. Test for Nitrate: 
To 1 gm of the EC, copper turnings was added and again conc.H2SO4 was 
added, heated and the test tube was tilted vertically down and observed for any 
changes. 
4.2.5 MICROBIAL ACTIVITY: 
AGAR- WELL DIFFUSION METHOD 
[62]
 
PRINCIPLE 
The antimicrobials present in the samples are allowed to diffuse out into the medium 
and interact in a plate freshly seeded with the test organisms. The resulting zones of 
inhibition will be uniformly circular as there will be a confluent lawn of growth. The 
diameter of zone of inhibition can be measured in millimeters. 
MATERIALS REQUIRED 
1Muller Hinton Agar Medium (1 L) 
The medium was prepared by dissolving 33.8 g of the commercially available Muller 
Hinton Agar Medium (MHI Agar Media) in 1000ml of distilled water. The dissolved 
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medium was autoclaved at 15 lbs pressure at 121°C for 15 minutes. The autoclaved 
medium was mixed well and poured onto 100mm petriplates (25-30ml/plate) while 
still molten. 
2. Nutrient broth (1L) 
One litre of nutrient broth was prepared by dissolving 13 g of commercially available 
nutrient medium (HI Media) in 1000ml distilled water and boiled to dissolve the 
medium completely. The medium was dispensed as desired and sterilized by 
autoclaving at 15 lbs pressure (121ºC) for 15 minutes. 
3. Streptomycin (standard antibacterial agent, concentration: 10mg / ml) 
4. Culture of test organisms; growth of culture adjusted according to McFarland 
Standard, 0.5% 
1. E.coli (ATCC 25922) 
2. Staphylococcus aureus (ATCC 25923) 
3. Pseudomonas aeroginosa (ATCC 27853)  
4. Klebsiella pneumoniae (ATCC 13883) 
PROCEDURE 
Petriplates containing 20ml Muller Hinton Agar Medium were seeded with bacterial 
culture of E.coli, Pseudomonas aeroginosa, Klebsiella pneumoniae and 
Staphylococcus aureus (growth of culture adjusted according to McFarland Standard, 
0.5%). Wells of approximately 10mm was bored using a well cutter and different 
concentrations of sample such as 250μg/mL, 500μg/mL and 1000μg/mL were added. 
The plates were then incubated at 37°C for 24 hours. The antibacterial activity was 
assayed by measuring the diameter of the inhibition zone formed around the well 
(NCCLS, 1993). Streptomycin was used as a positive control. 
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ANTIFUNGAL ACTIVITY
[63]
 
AGAR- WELL DIFFUSION METHOD  
PRINCIPLE 
In order to access the biological significance and ability of the sample, the antifungal 
activity was determined by Agar well diffusion method. The antifungals present in 
the samples are allowed to diffuse out into the medium and interact in a plate freshly 
seeded with the test organisms. The resulting zones of inhibition will be uniformly 
circular as there will be a confluent lawn of growth. The diameter of zone of 
inhibition can be measured in millimeters. 
MATERIALS REQUIRED 
1) Potato Dextrose Agar Medium (1 L) 
The medium was prepared by dissolving 39 g of the commercially available Potato 
Dextrose Agar Medium (HiMedia) in 1000ml of distilled water. The dissolved 
medium was autoclaved at 15 lbs pressure at 121°C for 15 minutes. The autoclaved 
medium was mixed well and poured onto 100mm petriplates (25-30ml/plate) while 
still molten. 
3. Clotrimazole (standard antifungal agent, concentration: 10mg / ml) 
4. Culture of test organisms; growth of culture adjusted according to McFarland 
Standard, 0.5% 
 Aspergillus niger (ATCC 16404)  
PROCEDURE 
Potato Dextrose agar plates were prepared and overnight grown species of fungus, 
Aspergillus niger were swabbed. Wells of approximately 10mm was bored using a 
well cutter and samples of different concentrations such as 250μg/mL, 500μg/mL and 
1000μg/mL were added. The zone of inhibition was measured after overnight 
incubation at room temperature and compared with that of standard antimycotic 
(Clotrimazole) (NCCLS, 1993). 
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4.2.6 INSTRUMENTAL ANALYSIS 
SOPHISTICATED INSTRUMENTAL ANALYSIS 
FT IR - Fourier Transform Infra-red Spectroscopy 
[64] 
FTIR (Fourier Transform Infra-red Spectroscopy) is a sensitive technique 
particularly for identifying organic chemicals in a whole range of applications 
although it can also characterise some inorganics. Examples include paints, 
adhesives, resins, polymers, coatings and drugs. FTIR is an effective analytical 
instrument for detecting functional groups. 
 
 
 
 
 
                                   
 
 
 
Fig no 3.1:  FTIR INSTRUMENT 
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Fig no 3.2: FTIR MECHANISM 
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APPLICATIONS: 
 Quantative scans 
 Qualitative scan solids, liquids, gasses 
 Organic samples, inorganic samples 
 Unknown identification  
 Impurities screening 
 Formulation 
 Pharmaceuticals  
Principle:  
Spectrophotometric tests are commonly used in the Identification of chemical 
substances and quantification of polymorphic forms. The test procedures are 
applicable to substances that absorb IR radiation. The IR absorption spectrum of a 
substance compared with that obtained concomitantly for the corresponding reference 
standard / reference substance provide conclusive evidence of the identity of the 
substance being tested.  
Recording Infrared spectrum of a solid as a disc (as per USP ‹197K›):  
 Triturate about 1 to 2 mg of the substance to be examined with 300 to 400 mg, 
unless otherwise specified, of finely powdered and dried potassium bromide. 
If the substance is a hydrochloride it is preferable to use potassium chloride.  
 Carefully grind the mixture and spread it uniformly in a suitable die.  
 Submit it to the pressure of about 800 mPa (8 tons/ cm2).  
 Examine the disc visually and if any lack of uniform transparency is observed, 
reject the disc and prepare again.  
 Record the spectrum between 4000 to 650 cm-1 unless otherwise specified in 
individual standard test procedure.  
 When sample and standard are measured for concordance, the transmittance 
obtained at the start of the scan range, should not deviate by more than 10% 
between them (For eg. If the standard shows a transmittance of 75%, the 
sample transmittance can be between 65% and 85%). 
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FT-IR was the most advanced and the major advantage was its 
 Speed 
 Sensitivity 
 Mechanical Simplicity 
 Internally Calibrated    
ICPOES (INDUCTIVELY COUPLED PLASMA OPTIC EMISSION 
SPECTROMETRY) 
 
 
 
 
 
             
     
  
 
 
 
 
Fig no 4.1 ICPOES Instrument 
Manufacturer: Perkin Elmer 
Model:  Optima 5300 DV ICP-OES Inductively Coupled Plasma Spectrometer (ICP) 
Principle: 
An aqueous sample was converted to aerosols via a nebulizer. The aerosols 
are transported to the inductively coupled plasma which was a high temperature zone 
(8,000– 10,000ºC). The analysts are heated (excited) to different (atomic and/or ionic) 
states and produce characteristic optical emissions (lights). These releases are 
separated based on their respective wavelengths and their strengths are measured 
(spectrometry). The intensities are proportional to the concentrations of analyses in 
the aqueous sample. The quantification was an external multipoint linear 
standardization by comparing the emission intensity of an unknown sample with that 
of a standard sample. Multi-element calibration standard solutions are prepared from 
single- and multi element primary standard solutions. With respect to other kinds of 
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analysis where chemical speciation was relevant (such as the concentration of ferrous 
iron or ferric iron), only total essential concentration was analysed by ICP-OES.
 [65] 
Application: 
The analysis of major and minor elements in solution EC  
Objectives: 
 Determine elemental concentrations of different metals. 
 Learn principles and operation of the ICP-OES instrument 
 Develop and put on a method for the ICP-OES sample analysis 
 Enhance the instrumental conditions for the analysis of different elements 
 probes the outer electronic structure of atoms  
Mechanism:  
In plasma emwassion spectroscopy (OES), a ECM solution was presented into 
the core of inductively coupled argon plasma (ICP), which generates temperature of 
approximately 8000°C. At this temperature all elements become thermally excited 
and emit light at their characteristic wavelengths. This light was collected by the 
spectrometer and passes through a diffraction grating that serves to resolve the light 
into a spectrum of its essential wavelengths. Within the spectrometer, this deflected 
light was then collected by wavelength and amplified to yield an strength of  
measurement that can be converted to an elemental concentration by comparison with 
standardization values.
[66] 
The Inductively coupled plasma optical emission spectrometric (ICP-OES) 
analysis was done in SAIF, IIT MADRAS, and Chennai-36 using Perkin Elmer 
Optima 5300 DV. 
 
 
 
 
 
 
 
 
 
 
Fig no 4.2 ICPOES Mechanism 
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SEM - Scanning Electron Microscope 
[67] 
DEFINITION
 
Scanning Electron Microscopy (SEM), also known as SEM analysis or SEM 
microscopy, is used very effectively in microanalysis and failure analysis of solid 
inorganic materials. Scanning electron microscopy is performed at high 
magnifications, generates high-resolution images and precisely measures very small 
features and objects.
 
SEM ANALYSIS APPLICATIONS 
The signals generated during SEM analysis produce a two-dimensional image 
and reveal information about the sample including: 
External morphology (texture) 
 Chemical composition (when used with EDS) Orientation of materials making 
up the sample 
The EDS component of the system is applied in conjunction with SEM analysis to: 
 Determine elements in or on the surface of the sample for qualitative 
information 
 Measure elemental composition for semi-quantitative results 
 Identify foreign substances that are not organic in nature and coatings on 
metal 
 SEM Analysis with EDS – qualitative and semi-quantitative results 
 Magnification – from 5x to 300,000x 
 Sample Size – up to 200 mm (7.87 in.) in diameter and 80 mm (3.14 in.) in 
height 
 Materials analysed – solid inorganic materials including metals and minerals. 
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Fig no 5.1 SEM INSTRUMENT 
 
 
 
 
 
 
 
 
 
 
Fig no: 5.2 SEM MECHANISMS 
THE SEM ANALYSIS PROCESS 
Scanning Electron Microscopy uses a focused beam of high-energy electrons 
to generate a variety of signals at the surface of solid specimens. In most SEM 
microscopy applications, data is collected over a selected area of the surface of the 
sample and a two-dimensional image is generated that displays spatial variations in 
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properties including chemical characterization, texture and orientation of materials. 
The SEM is also capable of performing analyses of selected point locations on the 
sample. This approach is especially useful in qualitatively or semi-quantitatively 
determining chemical compositions, crystalline structure and crystal orientations. 
The EDS detector separates the characteristic X-rays of different elements into 
an energy spectrum and EDS system software is used to analyse the energy spectrum 
in order to determine the abundance of specific elements. A typical EDS spectrum is 
portrayed as a plot of X-ray counts vs. energy (in keV). Energy peaks correspond to 
the various elements in the sample. Energy Dispersive X-ray Spectroscopy can be 
used to find the chemical composition of materials down to a spot size of a few 
microns and to create element composition maps over a much broader raster area. 
Together, these capabilities provide fundamental compositional information for a 
wide variety of materials, including polymers. In scanning electron microscope high-
energy electron beam was focused through a probe towards PP. Variety of signals 
was produced on interaction with the surface of the sample. This results in the 
emission of electrons or photons and it was collected by an appropriate detector. 
The types of signal produced by a scanning electron microscope include:  
 Secondary electrons 
 Back scattered electrons 
 Characteristic x-rays light 
 Specimen current 
 Transmitted electrons. 
This gives the information about the sample and it includes external morphology, 
texture, its crystalline structure, chemical composition and it displays the shape of the 
sample. 
XRD - X-ray Powder Diffraction (XRD) 
[68] 
X-ray powder diffraction (XRD) is a rapid analytical technique primarily used 
for phase identification of a crystalline material and can provide information on unit 
cell dimensions. The analysed material is finely ground, homogenized, and average 
bulk composition is determined. 
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DEFINITION 
X-ray powder diffraction is most widely used for the identification of 
unknown crystalline materials (e.g. minerals, inorganic compounds). Determination 
of unknown solids is important to studies in geology, environmental science, material 
science and biology. 
 
 
 
      
 
     
 
   
 
     
 
 
 
 
Fig no 6.1: XRD - X-ray Powder Diffraction Instrument  
 
 
 
 
 
 
Fig no 6.2 XRD Mechanism 
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Applications:  
 Characterization of crystalline materials   
 Identification of fine-grained minerals such as clays and mixed layer clays 
that are difficult to determine optically  
 Determination of unit cell dimensions.  
With specialized techniques, XRD can be used to:  
 Determine crystal structures using Rietveld refinement  
 Determine of modal amounts of minerals (quantitative analysis)  
 Characterize thin films samples by:  
 Determining lattice mismatch between film and substrate and to inferring 
stress and strain  
 determining dislocation density and quality of the film by rocking curve 
measurements  
 measuring super lattices in multilayered epitaxial structures  
 determining the thickness, roughness and density of the film using glancing 
incidence X-ray reflectivity measurements  
 Make textural measurements, such as the orientation of grains, in a 
polycrystalline sample. 
Strengths and Limitations of X-ray Powder Diffraction:   
Strengths:  
 Powerful and rapid (< 20 min) technique for identification of an unknown 
mineral  
 In most cases, it provides an unambiguous mineral determination  
 Minimal sample preparation is required  
 XRD units are widely available  
 Data interpretation is relatively straight forward.  
Limitations:  
 Homogeneous and single-phase material is best for identification of unknown  
 Must have access to a standard reference file of inorganic compounds   
 Requires tenths of a gram of material which must be ground into a powder  
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 For mixed materials, detection limit is ~ 2% of sample  
 For unit cell determinations, indexing of patterns for non-isometric crystal 
systems is complicated.  
Sample Collection and Preparation:  
Determination of an unknown requires: the material, an instrument for grinding, and a 
sample holder.  
 Obtain a few tenths of a gram (or more) of the material, as pure as possible  
 Grind the sample to a fine powder, typically in a fluid to minimize inducing 
extra strain (surface energy) that can offset peak positions, and to randomize 
orientation. Powder less than ~10 ȝm (or 200-mesh) in size is preferred  
 Place into a sample holder or onto the sample surface. 
4.3 TOXICOLOGICAL STUDIES 
4.3.1 ACUTE ORAL TOXICITY STUDY 
Acute toxicity study was carried out as per OECD guideline (Organization for 
Economic Co - operation and Development, Guideline-423 
[69]
. 
The experimental protocol was approved by the institutional ethical 
committee (IAEC) under CPCSEA (IAEC approved number: 
04/321/PO/Re/S/01/CPCSEA-12/OCT-2018 
These studies were conducted in C.L.Baid Metha College of Pharmacy, 
Dhuraipakkam, Chennai. 
INTRODUCTION: 
  The acute toxic class method is a stepwise procedure with the use of 3 
animals of a single sex per step. 
 Depending on the mortality and/or the moribund status of the animals, on 
average 2-4 steps may be necessary to allow judgement on the acute toxicity 
of the test substance.  
 This procedure is reproducible, uses very few animals and is able to rank 
substances in a similar manner to the other acute toxicity testing methods.  
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 The acute toxic class method is based on biometric evaluations with fixed 
doses, adequately separated to enable a substance to be ranked for 
classification purposes and hazard assessment.  
 In principle, the method is not intended to allow the calculation of a precise 
LD50 but does allow for the determination of defined exposure ranges where 
lethality is expected since death of a proportion of the animals is still the 
major endpoint of this test.  
 The method allows for the determination of an LD50 value only when at least 
two doses result in mortality higher than 0% and lower than 100%.  
The use of a selection of pre-defined doses, regardless of test substance, with   
classification explicitly tied to number of animals observed in different states 
improves the opportunity for laboratory to laboratory reporting consistency and 
repeatability.  
PRINCIPLE:  
It is the principle of the test that based on a stepwise procedure with the use of 
a minimum number of animals per step, sufficient information is obtained on the 
acute toxicity of the test substance to enable its classification. The substance is 
administered orally to a group of experimental animals at one of the defined doses. 
The substance is tested using a stepwise procedure, each step using three animals of a 
single sex. Absence or presence of compound-related mortality of the animals dosed 
at one step will determine the next step, i.e.;  
       − No further testing is needed 
       − dosing of three additional animals with the same dose  
       − dosing of three additional animals at the next higher or the next lower dose 
level. 
The method will enable a judgment with respect to classifying the test 
substance to one of a series of toxicity classes.  
METHODOLOGY   
Selection of Animal Species  
 The preferred rodent species is the wister rat, although other rodent species 
may be used. Healthy young adult animals are commonly used laboratory strains 
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should be employed. Females should be nulliparous and non-pregnant. Each animal, 
at the commencement of its dosing, should be between 6 to 8 weeks old and the 
weight (150-250gm) should fall in an interval within±20 % of the mean weight of any 
previously dosed animals.  
Housing and Feeding Conditions 
 The temperature in the experimental animal room should be 22ºC + 3ºC.  
Although the relative humidity should be at least 30% and preferably not exceed 70% 
other than during room cleaning the aim should be 50-60%. Lighting should be 
artificial, the sequence being 12 hours light, 12 hours dark. For feeding, conventional 
laboratory diets may be used with an unlimited supply of drinking water. Animals 
may be group-caged by dose, but the number of animals per cage must not interfere 
with clear observations of each animal. 
Preparation of animals:   
  The animals are randomly selected, marked to permit individual identification, 
and kept in their cages for at least 7 days prior to dosing to allow for acclimatization 
to the laboratory conditions. 
 Test Animals and Test Conditions:  
 Sexually mature Female Wistar albino rats (150-200gm) were obtained from 
TANUVAS, Madhavaram, Chennai. All the animals were kept under standard 
environmental condition (22±3°C).  The animals had free access to water and 
standard pellet diet (Sai Meera foods, Bangalore).  
PREPARATION OF ACUTE TOXICITY STUDIES: 
 Rats were deprived of food overnight (but not water 16-18 h) prior to 
administration of the, Eladhi chooranam.  
The principles of laboratory animal care were followed and the Institutional 
Animal Ethical Committee approved the use of the animals and the study design 
IAEC approved  Number: 04/321/PO/Re/S/01/CPCSEA-12/OCT-2018 
Test Substance  : ELADHI CHOORANAM 
Animal Source  : TANUVAS, Madhavaram, Chennai.   
Animals   : Wister Albino Rats (Female-3+3) 
Age    : 6-8 weeks 
Body Weight on Day 0 : 150-200gm. 
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Acclimatization  : Seven days prior to dosing. 
Veterinary examination : Prior and at the end of the acclimatization period. 
Identification of animals : By cage number, animal number and individual  
                   marking by using Picric acid.  
Number of animals               : 3 Female/group,  
 Route of administration      :   Oral  
Diet : Pellet feed supplied by Sai meera foods Pvt Ltd, 
Bangalore 
Water    : Aqua guard portable water in polypropylene bottles. 
Housing & Environment : The animals were housed in Polypropylene cages  
                   provided with bedding of husk. 
Housing temperature :  between 22ºC + 3ºC.    
Relative humidity  :  between 30% and 70%, 
Air changes    : 10 to 15 per hour and  
Dark and light cycle   : 12:12 hours. 
Duration of the study : 14 Days   
Administration of Doses:  
 EC was suspended in water and administered to the groups of wistar albino 
rats in a single oral dose by gavage using a feeding needle. The control group 
received an equal volume of the vehicle. Animals were fasted 12 hours prior to 
dosing. Following the period of fasting, the animals were weighed and then the test 
substance was administered. Three Female animals are used for each group. The dose 
level of 3mg/kg body weight was administered. After the substance has been 
administered, food was withheld for a further 3-4 hours. The principle of laboratory 
animal care was followed. Observations were made and recorded systematically and 
continuously as per the guideline after substance administration. 
  
The visual observations included skin changes, mobility, aggressively, 
sensitivity to sound and pain, as well as respiratory movements. Finally, the number 
of survivors was noted after 24 hrs and these animals were then monitored for a 
further 14 days and observations made daily. The toxicological effect was assessed on 
the basis of mortality. 
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Limit test 
The limit test was primarily used in situations where the experimenter has 
information indicating that the test material was likely to be nontoxic, i.e., having 
toxicity only above regulatory limit doses. A limit test at one dose level of 2000 
mg/kg body weight was carried out with three animals per step.  
The test substance-related mortality was not produced in animals, so further 
testing at the next lower level need not be carried out.  
Observations 
 The animals were observed individually after dosing at least once during the 
first 30mins and periodically during the first 24 hours. 
 Special attention: First 1-4 hours after administration of drug.  
 It was observed daily thereafter for a total of 14 days, except when they 
needed to be removed from the study and killed humanely for animal welfare 
reasons or are found dead. 
a. Mortality 
Animals will be observed intensively at 0.5, 2.0, 4.0, 6.0, 12.0, 24.0 and 48.0 
hour following drug administration on day 1 of the experiment and daily twice 
thereafter for 14 days.   
b. Body weight 
Individual weight of animals was determined before the test substance was 
administered and weights will be recorded at day 1, 7, and 14 of the study. Weight 
changes were calculated and recorded. At the end of the test, surviving animals were 
weighed and humanly killed. 
c. Cage-side observation 
These include changes in skin and fur, eyes and mucous membranes and also 
respiratory, circulatory, autonomic and central nervous systems, somatomotor activity 
and behaviour patterns. Attention should be directed to observations of tremors, 
convulsions, salivation, diarrhoea, lethargy, sleep and coma. 
d. Gross necropsy 
All animals (including those which die during the test period are removed 
from the study) will be subjected to gross necropsy. Gross necropsy includes 
examination of the external surface of the body, all orifices, cranial, thoracic and 
                                                                           MATERIALS AND METHODS 
 
ANTI-HYPERTENSIVE ACTIVITY OF ELADHI CHOORANAM  97 
 
abdominal cavities and their contents, brain, eye, thymus, lungs, heart, spleen, liver, 
kidneys, adrenals, testes and uterus of all animals. 
Histopathology 
Microscopic examination will be carried out  in organs to show the evidence of 
any toxicity in gross pathology. 
Data and reporting 
All the data were summarised in tabular form, table showing the animals used, 
number of animals displaying signs of toxicity, the number animals found dead 
during the test or killed for humane reasons, a description and the time course of toxic 
effects and reversibility, and necroscopic findings. 
Test substance and Vehicle  
In order to ensure the uniformity in drug distribution in the medium the 
suspension was made by mixing EC with 2% CMC solution and it was found suitable 
for dose accuracy.  
Justification for choice of vehicle 
The vehicle selected as per the standard guideline is pharmacologically inert 
and easy to employ for new drug development and evaluation technique 
[70]
. 
4.3.2 REPEATED DOSE 28 DAYS ORAL TOXICITY STUDY OF VEN 
THAMARAIYATHI CHOORANAM ON RATS – (OECD-407 guidelines) [71] 
Test Substance  : ELADHI CHOORANAM 
Animal Source  : TANUVAS, Madhavaram, Chennai.   
Animals   : Wister Albino Rats (Male -24, and Female-24) 
Age    : 6-8 weeks 
Body Weight               : 150-200gm. 
Acclimatization  : Seven days prior to dose. 
Veterinary examination : Prior and at the end of the acclimatization period. 
Identification of animals      : By cage number, animal number   and    individual  
 marking by using    Picric acid 
Diet    : Pellet feed supplied by Sai meera foods Pvt Ltd,     
       Bangalore. 
Water    : Aqua guard portable water in polypropylene bottles. 
Housing & Environment : The animals were housed in Polypropylene cages  
       provided with bedding of husk. 
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Housing temperature :  between 22ºC + 3ºC.    
Relative humidity  :  between 30% and 70%. 
Air changes    : 10 to 15 per hour  
Dark and light cycle   : 12:12 hours. 
Duration of the study : 28 Day 
Table no 8: Animals and groups 
Justification for Dose Selection:  
The results of acute toxicity studies in Wistar albino rats indicated that (EC) was 
non-toxic and no behavioural changes was observed up to the dose level of 2000 mg/kg 
body weight. On the basis of body surface area ratio between rat and human, the doses 
selected as per OECD guideline three dose levels were selected for the study. They 
are low dose (5X), high dose (10X). X is calculated by multiplying the acute toxicity 
dose 2000mg) and the body surface area of the rat (0.018), 5X dose is (100mg/kg), 10X 
dose is (200mg/kg) The oral route was selected for use because oral route is considered to 
be a proposed therapeutic route. 
Preparation and Administration of Dose: 
        Eladhi chooranam suspended in prescribed medium, it was administered to 
animals at the dose levels of X, 5X, 10X. The test substance suspensions were freshly 
prepared every two days once for 28 days. The control animals were administered 
vehicle only. The drug was administered orally by using oral gavage once daily for 28 
consecutive days. 
METHODOLOGY 
Randomization, Numbering and Grouping of Animals 
48 Wistar Albino Rats (24M + 24F) were selected and divided into 4 groups. 
Each group consist of 12 animals (Male -6, and Female-6). First group treated as a 
control and other three groups were treated with test drug (low, mid, high) for 28 
Groups No of Rats 
Group I Vehicle control (Water) 12(6male,6 female) 
Group II EC- low dose X (20mg) 12 (6male,6 female) 
Group III EC- Mid dose 5X (100mg) 12 (6male,6female) 
Group IV EC- High dose 10X (200 mg) 12(6male,6female) 
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days. Animals were allowed acclimatization period of 7 days to laboratory conditions 
prior to the initiation of treatment. Each animal was marked with picric acid. The 
females were nulliparous and non-pregnant.  
OBSERVATIONS  
Experimental animals were kept under observation throughout the course of 
study for the following: 
Body Weight: 
Weight of each rat was recorded on day 0, at weekly intervals throughout the 
course of study.  
Food and water Consumption:  
Food and water consumed per animal was calculated for control and the 
treated dose groups. 
Clinical signs:  
All animals were observed daily for clinical signs. The time of onset, intensity 
and duration of these symptoms, if any, were recorded. 
Mortality: 
All animals were observed twice daily for mortality during entire course of 
study. 
Functional Observations:  
At the end of the 4
th
 week exposure, ‘sensory reactivity’ to graded stimuli of 
different types (auditory, visual and proprioceptive stimuli), ‘motor reactivity’ and ‘grip 
strength’ were assessed. 
Laboratory Investigations: 
Following laboratory investigations were carried out on day 29 in animal’s 
fasted over-night. Blood samples were collected from orbital sinus using sodium 
heparin (200IU/ml) for Bio chemistry and potassium EDTA (1.5 mg/ml) for 
Haematology as anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 
minutes. 
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Haematological Investigations: 
  Blood samples of control and experimental rats was analyzed for 
hemoglobin content, total red blood corpuscles (RBC), white blood corpuscles 
(WBC) count and packed cell volume (PCV). 
Biochemical Investigations: 
Serum was used for the estimation of biochemical parameters. Samples 
of control and experimental rats were analyzed for protein, bilirubin, urea, 
BUN, creatinine, triglyceride, cholesterol and glucose levels was carried using 
standard methods. Activities of glutamate oxaloacetate transaminase/Aspartate 
aminotransferase (GOT/AST), glutamate pyruvate transaminase/ Alanine amino 
transferase   (GPT/ALT)   and   alkaline   phosphatase   were   estimated   as   per   the 
colorimetric procedure. 
Necropsy: 
All the animals were sacrificed by excessive anaesthesia on day 29. Necropsy 
of all animals was carried out. 
Histopathology:  
Control and highest dose group animals will be initially subjected to 
histopathological investigations. If any abnormality found in the highest dose group 
than the low, then the mid dose group will also be examined. Organs will be collected 
from all animals and preserved in 10% buffered neutral formalin for 24 h and washed 
in running water for 24 h.  The organ sliced 5 or 6µm sections and were dehydrated in 
an auto Technicon and then cleared in benzene to remove absolute alcohol. 
Embedding was done by passing the cleared samples through three cups containing 
molten paraffin at 50°C and then in a cubical block of paraffin made by the “L” 
moulds. It was followed by microtome and the slides were stained with 
Haematoxylin-eosin red. 
Statistical analysis:  
Findings such as body weight changes, water and food consumption, and 
haematology and blood chemistry were subjected to One-way ANOVA followed by 
dunnet-t test using a computer software programme – Graph pad version 7. All data 
were summarized in tabular form, (Table-24 to 33) 
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4.4 PHARMACOLOGICAL STUDIES 
4.4.1 ANTI-HYPERTENSIVE ACTIVITY OF ELADHI CHOORANAM IN 
SPOTANEOUSLY HYPERTENSIVE RATS 
Cardiovascular disease is a leading cause of death, and hypertension is a 
critical risk factor for cardiovascular events. The pathogenesis of hypertension is 
accompanied by decreased nitric oxide (NO) bioavailability in the vasculature and 
increased cardiovascular remodelling. Hypertensive patients frequently develop 
clinically evident cardiac hypertrophy 10 to 20 years after the onset of hypertension, 
as a result of adaptive and maladaptive responses to pressure overload. Cardiac 
hypertrophy has been linked to the development of a variety of cardiovascular 
diseases, including myocardial ischemia, arrhythmias, and sudden cardiac death. 
Therefore, treatment options that not only maintain stable pressure levels but also 
delay or even regress the structural and functional changes in resistance arteries and 
the heart are needed. Despite the current availability of multiple anti-hypertensive 
medication types, a significant number of patients do not respond to treatment and 
remain hypertensive. As multiple mechanisms likely contribute to the development of 
hypertension, including angiotensin, oxidative stress and hemodynamic changes, 
multi-targeted therapeutic interventions will likely be required for effective 
management of hypertension. 
Animals:  
All animal experiments were performed in accordance with the Guidelines of 
OECD. All experiments were performed with the approval of IAEC of C.L. BAID 
METHA COLLEGE OF PHARMACY. SHR (9 weeks old) and age-matched Wistar 
rats male, weighing 250±20 g, were purchased from King Institute of Preventive 
Medicine and Research, Rats were kept in a room temperature-controlled room (25 
°C), with 12 hours dark and 12 hours artificial illumination daily (7:00— 19:00). 
Food and water were available ad libitum. 
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GROUPING 
The animals were divided into following groups: 
 Group 1 control untreated group which received normal saline.  
 Group 2 received Verapamil 12.5 mg/kg b.w 
 Group 3 EC 200 mg/kg b.w 
 Group 4 EC  400mg/kg b.w 
The drug EC was administered orally and once daily for 4 weeks. 
In this study, the effect of a four weeks chronic administration of daily oral 
doses of 200 and 400 mg/kg body weight, EC on blood pressure was measured. 
  The stock solution was prepared once every three days. Extract suspensions 
were stored at 4ºC and were allowed to reach room temperature before 
administration. 
METHOD: 
Systolic blood pressure (SBP) and heart rate measurement of SH rats was 
carried out using tail-cuff method plethysmography (LE 5001 Pressure Meter). A 
mean of six measurements was obtained for each animal. For blood pressure 
measurement, the animals were warmed up to 42°C for 5 min in a confinement cage. 
The animals were first submitted to a period of adaptation for 15 days before the 
experiments and only SHR with an SBP > 170 mmHg were selected for this study.  
During the final week of the treatment, the rats were allowed to acclimatize to 
the experimental conditions of non-invasive SBP measurements by allowing them to 
stand in rat restrainers for 30 min every day. SBP measurements were recorded 24 
hours after the last treatment dose. At least 8-10 recordings were taken for each rat 
and the mean of the lowest 4 values within less than 10 mmHg difference was taken 
as the mean SBP 
[72]
. 
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4.4.2 DIURETIC ACTIVITY OF ELADHI CHOORANAM
 [73] 
ANIMALS 
Male Wistar rats (175-200g) were purchased from TANUVAS Chennai. They 
were maintained under standard conditions of temperature and humidity. The method 
of Lipschitz et al was employed for the assessment of diuretic activity.  FOUR groups 
of six rats.   
GROUPING 
The animals were divided into following groups: 
 Group 1----control untreated group which received normal saline.  
 Group 2 ----received Furosemide12.5 mg/kg b.w 
 Group 3-----200mg/kg b.w 
 Group 4-----400mg/kg b.w 
Each were fasted and deprived of water for eighteen hours prior to the 
experiment. On the day of experiment, normal group of animals were given normal 
saline orally (25 ml/kg body weight.)  And the treated groups were given 100,200 EC 
mg/kg bodyweight of rats and water.  The standard groups were given furosemide 
(20mg/kg) intra peritoneal. The rats were placed in metabolic cages specially 
designed to separate faecal matter and urine. The urine volume was collected at 24 
hours post administration. During this period no food or water was given to the 
animals. The total urine volume was measured for both control and treated animals. 
The sodium, potassium and chloride ion concentration in the urine samples were 
determined.  
The urine was collected for 5
th
 hour and 24
th
 hour after administration control, 
standard and test drug. The bladder was emptied by pull the base of tail of each rat
[74] 
OBSERVATION 
 Animals are subjected to collect urine periodically by metabolic cages. 
 Diuretic assay parameters were observed for each rat. 
 The total volume of urine was measured. 
 Urinary pH, urinary sodium excretion, urinary potassium excretion, 
urinary chloride excretions are determined. The concentration of sodium, 
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potassium and chloride levels excreted in the urine were measured by 
flame photometry
 
and the chloride concentration was estimated by titration 
with silver nitrate solution(N/50) using 3 drops of 5% potassium chromate 
as indicator 
[75]
 
 The data was analyzed using one-way analysis of variance (ANOVA). 
 The statistical significance of the difference of the means was evaluated 
by Dunnett’s multiple comparison test 
4.4.3 ANTI-OXIDANT ACTIVITY OF ELADHI CHOORANAM 
DPPH ASSAY (2, 2-diphenyl -1-picrylhydrazyl) IN-VITRO
 [76] 
     The radical scavenging activity of different extracts was determined by 
using DPPH assay according to 
[74]
 Chang et al [2001]. The decrease in the absorption 
of the DPPH solution after the addition of an antioxidant was measured at 517 nm. 
Ascorbic acid (10mg/ml DMSO) was used as reference. 
PRINCIPLE  
1,1-diphenyl-2-picrylhydrazyl is a stable free radical with red colour which 
turns yellow when scavenged. The DPPH assay uses this character to show free 
radical scavenging activity. The scavenging reaction between (DPPH) and an 
antioxidant (H-A) can be written as,  
DPPH + [H-A] →DPPH-H + (A) 
Antioxidants react with DPPH and reduce it to DPPH-H and as consequence 
the absorbance decreases. The degree of discoloration indicates the scavenging 
potential of the antioxidant compounds or extracts in terms of hydrogen donating 
ability. 
REAGENT PREPARATION 
0.1ml DPPH solution was prepared by dissolving 4mg of DPPH in 100ml of 
ethanol.  
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PROCEDURE 
Different volumes (1.25-20µg/µl) of EC extracts were made up to 40µl with 
DMSO and 2.96ml DPPH (0.1mm) solution was added. Their action mixture was 
incubated in dark condition at room temperature for 20min. After 20min, the 
absorbance of the mixture was read at 517 nm. 3ml of DPPH was taken as control. 
The % radical scavenging activity of the EC extracts was calculated using the 
following formula, 
        
         Control-Test 
% inhibition =            × 100 
           Control 
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                                 5. RESULTS AND DISCUSSION 
There are so many advanced studies have been carried out to bring the 
efficacy and potency of the drug “Eladhi chooranam”. The study includes literary 
collections, organoleptic characters, physicochemical, phytochemical analysis, Acid-
Base radical test, Microbial load, instrumental analysis, toxicological study and 
pharmacological study. The drug “Eladhi Chooranam” has been selected for Anti-
Hypertensive activity in reference with the text “Sarabenthirar Vaithya Muraigal ”.  
Literary collections about the drug from various text books were done. Siddha 
literatures related to the drug bring the evidence and importance of its utility in 
treating the hypertension.
 
  Botanical aspect explains the identification, description, active principle and 
medicinal uses of the plants. 
  Gunapadam review brings the effectiveness of the drug in treating 
hypertension.   
 The pharmacological review explains about the methodology of Anti- 
Hypertensive Activity and the drugs used. 
 Pharmaceutical review describes about the chooranam and its properties. 
 Lateral research gives the effectiveness of the drug in treating hypertension. 
 Siddha and Modern aspect of the disease was also reviewed. 
DISCUSSION ON STANDARDIZATION TECHNIQUES: 
STANDARDIZATION OF THE TEST DRUG 
Standardization of the drug is more essential to derive the efficacy, potency of 
the drug by analysing it by various studies. Following are the results of 
physicochemical and phytochemical analysis; physical characterisation and estimation 
of basic and acidic radicals have been done and tabulated. 
Toxicological results of the drug and pharmacological activity of the drug 
were derived. Its result has been tabulated and interpretation was made below. Thus, it 
is to give a complete justification to bring the effectiveness of the trial drug “Eladhi 
Chooranam”. 
                                                                RESULT S AND DISCUSSION 
 
ANTI-HYPERTENSIVE ACTIVITY OF ELADHI CHOORANAM  107 
 
ORGANOLEPTIC CHARACTERS 
The following characters have been noted in Eladhi chooranam. 
Table no 9: Organoleptic Characters of Eladhi chooranam 
Colour Brown 
Odour Pleasant  
Taste Bitter & sweet 
Texture Fine powder 
Particle size Completely pass  
through sieve no 88 
 
Discussion: 
  The organoleptic characters of the drug Eladhi chooranam showed yellowish 
green colour since prepared from dry herbs, Bitter and sweet in taste which might be 
responsible for the activity mentioned earlier and on sight they are fine powder. 
 The fineness of the chooranam represents easy absorption and better 
availability of the drug. 
 The size of the particle is reduced through various stages like pounding, 
sieving, filtering through white cloth ( vasthirakayam) 
 Only if the size of the particle is reduced to micro particles, the drug is easily 
absorbable in the digestive system. 
 The above processes reduced the size of particle so that the chooranam   
passes through the sieve no 88. 
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PHYSICO CHEMICAL ANALYSIS 
Table no 10: Results of Physico chemical analysis of Eladhi chooranam  
S.No Parameter Result 
1. P
H 
4.24 
2. Solubility         Positive 
Distilled water        Soluble 
Benzene        Soluble 
3.  Loss on drying 9.61% 
4.  Total ash value 5.47% 
5.  Acid insoluble Ash (%) 1.5% 
6.  Water soluble ash (%) 0.99% 
7.  Water soluble extraction 21.6% 
8.  Alcohol soluble extraction 16% 
 
Discussion: 
The physico chemical analysis of the drug result reveals the pH, Solubility, 
Loss of drying, Total ash value, Water soluble ash and Acid insoluble ash.  
Solubility:  
 Solubility is one of the important parameters to achieve desired concentration 
of drug in systemic circulation for desired (anticipated) pharmacological 
response. 
 Oral ingestion is the most convenient and commonly employed route of drug 
administration; oral bio-availability depends on solubility. 
 EC is soluble in major solvents and sparingly soluble in some solvents, well 
soluble in Distilled water, Benzene. It improves that its efficiency of solubility 
and increases the bio- availability of the test drug
 [77]
.  
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pH:  
 The pH level plays a role in enzyme activity by maintaining the internal 
environment, thus it exhibits important role in regulating homeostasis. 
 Eladhi chooranam shows weak acidic pH 4.24. 
 Weak acid is more lipids soluble in an acidic solution, and more water soluble 
in alkaline solution. 
 Whenever a weak acid drug is given, most of the drug in the stomach is in un-
ionized form, which forms through the gastric mucosa. Weakly acidic drugs 
are more readily absorbed from an acid medium (stomach) than are weakly 
basic drugs. 
 It is also important factor for drug absorption. This enhances the bio-
availability.
 [78]
 
Loss on drying: 
  Loss on drying (LOD) gives the total amount of volatile content and moisture     
(water) present in the drug.  
 The stability of a drug and its shelf-life are dependent on moisture content. 
 Moisture increase can adversely affect the active ingredient. 
 Low moisture content- drug could get maximum stability and better shelf life. 
 Since the EC has low loss on drying, the moisture content is 9.61% which is 
suitable for medicine preparation. 
Ash:  
 Ash values are helpful in determining the quality and purity of the drugs 
 The ash content of a crude drug is generally taken to be the residue remaining 
after incineration. It usually represents the inorganic salts naturally occurring 
in the drug and adhering to it, but it may also include inorganic matter added 
for the purpose of adulteration 
[79]
.  
 The total ash value of Eladhi chooranam is 5.47%, which determines the 
presence of inorganic content. 
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Acid insoluble ash:  
 The total ash is the residue remaining after incineration. The acid insoluble ash 
is the part of the total ash which is insoluble in diluted hydrochloric acid. 
 Lower the acid insoluble value better will be the drug quality. The drug 
ensures a low value of acid insoluble ash indicating that the preparation did 
not contain any sand, dust and stones. 
 The Acid insoluble ash of Eladhi chooranam is 1.5% which ensures the trail 
drug does not contain any sand, dust and stones.  
Water soluble ash: 
 Decreased water soluble ash value indicates easy facilitation of diffusion and 
osmosis mechanisms. 
 The Water-soluble ash of Eladhi chooranam is 0.99% indication increase the 
facilitate of diffusion and osmosis.  
Water-soluble and Alcohol-soluble extraction 
 Water-soluble extractive values of ingredients and formulation of Eladhi 
chooranam are depicted in table which shows 21.6%. 
 Higher water-soluble extractive value implies that water is a better solvent of 
extraction for the formulation than ethanol. 
 Alcohol-soluble extractive values of ingredients and formulation of Eladhi 
chooranam are depicted in table which shows 16%. 
 The results of Alcoholic and Water-soluble extracts of the formulation show 
that alkaloids of the formulations are more soluble in water than alcohol and a 
higher water-soluble extractive value of the formulation depicts that water is a 
better solvent of extraction for the formulation than alcohol. 
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Table no 11: Results of phytochemical analysis of Eladhi chooranam 
+ve/-ve present or absent if component tested 
Fig No 15: Preliminary Phytochemical Analysis of Eladhi Chooranam 
 
 
 
 
 
 
 
 
S.no Phytochemicals Test name 
 
Result 
1. Alkaloids Dragendroff's Test 
 
+ve 
2. Glycoside Keller-Killiani  Test 
 
+ve 
3. Saponin Froth Test 
 
+ve 
4. Phenols Ferric chloride Test +ve 
5. Flavanoids Alkaline Reagent test +ve 
 
6. Proteins  Xanthoproteins Test +ve 
7. Diterpines Copper Acetate Test 
 
+ve 
8. Gum and Mucilage Extract +Alcohol 
 
+ve 
9. Quinones  NAOH+Extract +ve 
                                                                RESULT S AND DISCUSSION 
 
ANTI-HYPERTENSIVE ACTIVITY OF ELADHI CHOORANAM  112 
 
Discussion 
Phytochemicals are natural bioactive compounds, found in plants and fibres, 
which act as a defense system against diseases and more accurately protect against 
diseases. The phytochemical analysis reveals that the presence of Alkaloids, 
Glycosides, Saponin, Phenol, flavonoids, Protein, and Diterpines, Gum and Mucilage 
Alkaloids:  
 Alkaloids possess Vasodilators and anti-arrhythmic effects 
 Alkaloids are the active principles producing many essential effects in 
protecting the body
 [80]. 
Glycosides  
 Glycosides are Anti-oxidant activity in nature thus it plays major role in 
treating cardiac diseases
 [81]
. 
Saponin: 
 Saponins reduce an emulsification of fat molecules. Saponin binds with bile 
salt and cholesterol in the intestinal tract. Bile salts form small micelles with 
cholesterol facilitating its absorption. Saponin cause a reduction of blood 
cholesterol by preventing its re-absorption. 
 It has a property of Anti-oxidant and reduced the risk of heart diseases [82].   
Phenols: 
 They possess rich Anti-Oxidant property and protect body from oxidative 
stress
 [83]
 
Diterpene: 
 Diterpene has the property of exhibiting of vasorelaxant action and inhibiting 
of vasocontraction 
 So, it is helpful in reduction of blood pressure [84]. 
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Protein 
 They help in repairing cells and important for growth [85]. 
 Increasing protein intake may actually help to lowering systolic blood pressure 
by more than 2mmHg in comparison with intake of carbohydrates. 
 Both animal and plant proteins lowered BP and led to statistically significant 
reductions in HBP risk
 [86]
. 
 A synergistic effect of all these alkaloids, glycosides, phenols, triterpenes, 
flavanoids, quinones increases the potency of the drug against hypertension. 
Flavonoids 
 It is the most important group of polyphenol compounds in plants. 
 They improve the endothelial and capillary function 
 Reduces the risk of atherosclerosis. 
 They help in strengthening and protect the inner lining of the blood vessels 
 Flavonoids are a group of plant metabolites which provide health benefits 
through cell signaling pathways and antioxidant effects. 
 Flavonoids can exert their Anti-Oxidant activity by scavenging the free 
radicals, by chelating metal ions or by inhibiting enzymatic systems which 
are responsible for free radical generation 
[87]
. 
Tannin:  
 Tannins contains anti-oxidant effect which producing many essential effects in 
protecting the body. 
 Tannin impacts on blood pressure and urinary parameters. 
 Tannin contains ACE inhibitory effect [88]. 
Quinones 
 Quinone possesses anti-oxidant activity. 
 Quinone activation reduces blood pressure. 
 Prevent cardiovascular diseases [89]. 
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Table no 12: High Performance Liquid Chromatography (HPLC) analysis of 
Eladhi chooranam: 
HPLC analyses were done. HPLC analysis performed with Eladhi chooranam 
Chooranam revealed the presence of following compounds:                    
S. NO  PARAMETERS METHOD  UNITS RESULTS 
 
1.  Total Polyphenol as gallic 
acid Equivalent  
Indian Pharmacopoeia 
2014  
mg/100g 0.52 
2.  Total Flavonoids as 
Quercetin Equivalent 
TNTH/STP/FOOD/110 mg/100g  6.20 
3.  Total Alkaloids   TNTH/STP/FOOD /426 mg/100g 3.26 
4.  Total Tannin as Tannic 
Acid Equivalent 
AOAC 20th Edn.2012, 
955.35 
mg/100g 2.10 
 
   
 
Chart no:1 Results of HPLC analysis 
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Interpretation: 
Polyphenols: 
 Polyphenols are protection and improving endothelial function with vascular 
relaxation and improves vascular health, thereby significantly reducing the 
risk of hypertension and CVD. 
 Polyphenols can stimulate the formation of vasoprotective factors such as 
nitric acid (NO) and endothelium derived hyperpolarizing factor to promote 
vasodilation. Polyphenols inhibits platelet aggregation in humans. 
 Polyphenols also improve vascular smooth muscle function, by reducing the 
excessive vascular oxidative stress of pathological blood vessels associated 
with many cardiovascular risk factors.    
 Polyphenols are the members of very large family of plant derived compound 
which had the anti-lipogenic effect. This is mainly due to the reduce fatty acid 
and triglycerol synthesis, increased in fatty acid oxidation and reduced 
oxidative stress and inflammation
 [90]
. 
Flavanoids: 
 Flavonoids are able to modulate blood pressure by restoring endothelial 
function, either directly or by affecting nitric acid levels.  
 Flavanoids comprise large group of secondary metabolites occurring widely 
throughout the plant kingdom. 
 Biological action of flavonoids, including anti-oxidant, anti aggregant and 
vasodilator affect.  
 Flavanoids can also reduce caloric intake and decrease body weight and fat 
deposition in visceral tissues. 
 Flavanoids are the unique antioxidant. It also corrects dislipidemia and blood 
pressure
 [91]
. 
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Tannin: 
 Tannins contains anti-oxidant effect which producing many essential effects in 
protecting the body. 
 Tannin contains ACE inhibitory effect [92]. 
BIOCHEMICAL ANALYSIS: 
Table no 13: Results of basic radical studies of Eladhi chooranam 
S.No Parameter Observation Result 
1. Test for Potassium Formation of yellow colour 
precipitate 
Positive 
 
2. Test for Calcium 
 
Formation of white colour 
precipitate 
Positive 
3. Test for Magnesium 
 
Formation of white colour 
precipitate 
Positive 
4. Test for Ammonium Appearance of brown colour Positive 
 
5. Test for Sodium Appearance of intense yellow 
colour 
Positive 
6. Test for Zinc Formation of white colour 
precipitate  
Positive 
 
Discussion 
The results of basic radical test show that the presence of Potassium (K
+
), 
Calcium (Ca), Magnesium (Mg), Sodium (Na) and Zinc (Zn). 
Potassium 
 Potassium is important for muscle function especially relaxing the wall of 
blood vessels. 
 This lowers the blood pressure and protects against muscle cramping. 
 This protects against an irregular heartbeat [93]. 
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Calcium: 
 Presence of calcium improves the physical strength of skeletal tissue. calcium 
ions are necessary for muscle contraction and transmission of nerve impulse. 
 Calcium is important for healthy blood pressure because it helps in 
vasoconstriction and vasodilatation of blood vessels
 [94]
.
 
Magnesium 
 Magnesium also helps in regulation of blood pressure and relaxing the blood 
vessels. 
 Magnesium act as a natural calcium channel blocker, increases nitric oxide, 
improves endothelial dysfunction and induces vasodilation 
[95]
.  
Ammonium Screenshot 
 Ammonium predicts clinical outcomes in Hypertensive kidney diseases  
 Ammonia may contribute to the vasodilatation and increase in cerebral blood 
flow. 
Sodium 
 Sodium also important for regulation of blood pressure [96] 
Zinc 
 Zinc have an Anti-oxidant property 
 Helps to protect cells in the body from damage caused by free radicals[97] 
Table no 14: Results of acid radical studies of Eladhi chooranam 
Discussion: 
The acidic radicals test shows the presence of Chloride and Nitrate. 
Sulphate  
 which is primarily used for its anticonvulsive effects in treating hypertensive 
disorders of pregnancy 
[98]
. 
Chloride 
 They help in maintenance of proper blood volume, blood pressure, pH of 
blood and also help in balance between ECF and ICF of cells
 [99]
.
 
S.NO Parameter Observation Result 
1. Test for Sulphate Appearance of white precipitate Positive 
2. Test for Chloride Formation of white precipitate Positive 
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ANTI-MICROBIAL ACTIVITY OF ELADHI CHOORANAM 
GRAM NEGATIVE BACTERIA  
Table no 15: Organism: E.coli 
Sample Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
Eladhi Chooranam 
(EC) 
Streptomycin (100µg) 26 
250 18 
500 21 
1000 25 
14mm – Low sensitive, 15mm – Moderate, 16mm – Highly sensitive 
Table no 16: Organism: Klebsiella  pneumoniae 
Sample Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
Eladhi Choornam (EC) Streptomycin (100µg) 25 
250 18 
500 20 
1000 23 
   14mm – Low sensitive, 15mm – Moderate, 16mm – Highly sensitive 
Table no 17: Organism: Pseudomonas aeroginosa 
Sample Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
Eladhi Choornam (EC) Streptomycin (100µg) 30 
250 20 
500 25 
1000 29 
14mm – Low sensitive, 15mm – Moderate, 16mm – Highly sensitive 
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GRAM POSITIVE BACTERIA 
Table no 18: Organism: Staphylococcus  aureus 
Sample Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
Eladhi Choornam (EC) Streptomycin (100µg) 26 
250 19 
500 23 
1000 27 
14mm – Low sensitive, 15mm – Moderate, 16mm – Highly sensitive 
Table no 19: Organism: Aspergillus niger 
Sample Concentration 
(μg/mL) 
Zone of inhibition       
(mm) 
Eladhi Choornam 
(EC) 
Clotrimazole(100µg)  37 
250 21 
500 25 
1000 32 
14mm – Low sensitive, 15mm – Moderate, 16mm – Highly sensitive 
Inference:  
1. Escherchia coli - Highly sensitive in 250(μg/mL) 
2. Klebsiella pneumoniae - Highly sensitive in 250 (μg/mL) 
3. Pseudomonas aeruginosa - Highly sensitive in 250(μg/mL) 
4. Staphylococcus aureus - Highly sensitive in 250 (μg/mL)  
5. Aspergillus niger - Highly sensitive in 250 (μg/mL) 
Discussion: 
The development of resistance against the presently available antibiotics arises 
the necessity of rediscovery of new anti-bacterial and anti-fungal agents in traditional 
systems of medicine. Different dosages of test drug against the microbes in 
antimicrobial activity of EC was compared with Standard drug Streptomycin and 
Clotrimazole (100μg)/ml disc for the following pathogens, they are Escherchia coli, 
Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus, 
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Aspergillus niger. The results represents EC potentially inhibit the growth of all above 
organism in 250μl, 500μl and 1000μl / disc. 14 mm – Low sensitive, 15 mm – 
Moderate, above 16 mm – Highly sensitive. The findings reveal that the Siddha drug 
EC have anti-microbial potency against bacterial and fungal pathogens which is used 
in the treatment of diseases.  
INSTRUMENTAL ANALYSIS 
FT-IR (Fourier Transform Infra-Red spectroscopy) 
Fourier Transform Infra-Red Spectroscopy (FTIR) analysis results in 
absorption spectra provide information about the functional group and molecular 
structure of a material. The results of Table no:20 and Fig no:7 shows the presence of 
functional group and inorganic compounds of Eladhi chooranam 
 
 
 
 
 
 
 
 
 
 
 
Fig no 7: FT-IR  Spectrum analysis 
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Table no 20: FTIR-INTERPRETATION of Eladhi chooranam 
 
Absorption peak cm
-1 
 
Stretch 
 
 
Functional group 
3430 O-H stretch, free hydroxyl Alcohols, Phenols 
2921 C-H Stretch Alkene 
2521 H-C=O:C-H Stretch Aldehydes 
1787 C=O Stretch 
 
Carbonyls (General) 
1478 N-O asymmetric Stretch  Nitro compounds 
1082 C-O Stretch Alcohols, Carboxylic 
acids, Esters, Ethers 
861 =C-H bend Alkenes 
712 N-H wag  1
0
, 2
0
 amines 
699 C-H “oop” Aromatics 
DISCUSSION 
FTIR instrumental analysis was done. The test drug was identified to have 9 
peaks. They are the functional groups present in the trial drug “Eladhi Chooranam”. 
The above table shows the presence of alcohol, Phenols, Alkenes, Aldehyde, 
Carbonyls, Nitro compounds, Carboxylic acids, Esters, Ethers, Amine, Aromatic 
groups which represent the peak value. 
 
Phenols: 
 It has possessed high Anti-Oxidant property which enhances the drug effect 
against the disease
 [100]
. 
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Alcohols:  
 The world Hypertension league speculated that the relatively greater effect 
alcohol on systolic blood pressure compared with diastolic blood pressure may 
indicate an imbalance between central nervous system factors influencing 
cardiac output and the peripheral vascular effects of alcohol. 
 There is increasing evidence that alcohol initiates central as well as peripheral 
reactions which in a synergistic manner have hypertensive action
 [101]
. 
Aldehydes: 
 The clear benefit and need for aldehyde-conjugating therapies exists for 
cardiovascular disease
 [102]
. 
Amines: 
 It enhances the drug effect against the disease. 
 Amines groups act as neurotransmitters. Amines are a class of compounds 
derived from ammonia by replacement of one or more effective antagonists of 
SSTR5 (Somatostatin receptor 5) and are used for treatment, control and 
prevention of disorders such as lipid disorders and obesity
 [103]
. 
Nitro groups: 
 Nitro groups containing drugs act directly on the vascular smooth muscle to 
cause relaxation and reduce the blood pressure
 [104] 
 
SEM: (SCANNING ELECTRON MICROSCOPE)
 
The particle size and the chemical elements were assessed by Scanning 
Electron Microscope. SEM is one of the most widely used instruments in research 
side. The SEM picture of Eladhi Chooranam is shown below. 
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Fig no 8: SEM analyses 
The particle morphology can be identified through these SEM images of 
Siddha medicine Eladhi chooranam. The particles are not spherical in shape. The size 
of the particles was approximately identified between 5-1micron. 
Discussion for SEM 
 Micro particles are defined as particulate dispersion or solid particles with a 
size in the range of 100-1000 nm in diameter. 
 Size and surface of micro particles can be easily manipulated to achieve both 
passive and active drug targeting. 
 They control and sustain the release of drug during the transportation and at the site of 
localization, alter the drug distribution in the body and subsequent clearance of the 
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drug so as to achieve increased drug therapeutic efficacy there by it increases the bio-
availability of the drug and reduced the side effects. 
Hence, Eladhi chooranam which is prepared biologically contains micro particles 
to enhance the pharmacological action in the target site 
[105]
.
 
ICP-OES (Inductively Coupled Plasma Optic Emission Spectrometry):
 
The drug sample Eladhi Chooranam was analysed by the Inductively Coupled 
Plasma Optic Emission Spectroscopy (ICP-OES) to detect the trace elements and 
other elements quantitatively. The result of (ICP-OES) is given on the  
Table No 21:  Results of ICP-OES 
S.No Elements Symbol Wavelength (nm) Concentration  
1. Aluminium (Al) 396.152 BDL 
2. Arsenic (As) 188.979 BDL 
3. Calcium (Ca) 315.807 13.105 mg/L 
4. Cadmium (Cd) 228.802 BDL 
5. Copper (Cu) 327.393 BDL 
6. Iron (Fe) 238.204 01.004 mg/L 
7.  Mercury (Hg) 253.652 BDL 
8.  Magnesium  (Mg) 285.213 01.274 mg/L 
9. Sodium (Na) 589.592 34.801 mg/L 
10. Nickel (Ni) 231.604 BDL 
11. Lead (Pb) 220.353 BDL 
12. Phosphorous (P) 213.617 98.107 mg/L 
 
Discussion: 
 The above results indicate that the trial drug is extremely safe as it contains 
heavy metals within specified limits. 
  In Eladhi Chooranam, the heavy metals like As, Cd, Hg, Pb and were below 
detectable level. This reveals the safety of the drug. 
 In addition Eladhi chooranam has the presence of Calcium (Ca) 13.105 mg/L, 
Iron (Fe) 01.004 mg/L, Magnesium (Mg) 01.274 mg/L, Sodium (Na) 34.801 
mg/L, Phosphorous (P) 98.107 mg/L are detected. 
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XRD (X-RAY DIFFRACTION METHOD) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig no 9: XRD analysis 
Discussion 
 The crystalline structure, the size and shape of the particles are highly 
dependent on the route of synthesis and highlight the efficacy of the drug. The nano 
particles may enhance bio absorption of the drug. 
 
XRD pattern of Eladhi chooranam shows the good crystallinity after 
calcinations process. The major diffraction peaks are identified after XRD analysis 
EC concluded that Nano crystalline range (21-33nm) is association with organic 
molecules probably plays an important role in making it biocompatible and nontoxic 
at therapeutic doses. Other elements present in EC act as additional supplement and 
possibly helps in increase the efficacy of the formulation 
[106]
. 
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TOXICITY STUDY RESULT 
ACUTE ORAL TOXICITY IN RATS – OECD 423 
Wistar albino rat was treated with the test drug Eladhi Chooranam of single 
dose of 2000mg/kg in 2% CMC as suspention. This study was conducted as per the 
OECD guidelines. The result of acute toxicity of Eladhi Chooranam has been 
tabulated below.  
 Dose finding experiment and its behavioural Signs of Toxicity for Eladhi 
Chooranam 
                                     Table no 22: Observation done  
SL              Group 
              CONTROL 
Observation SL Group 
TEST 
GROUP 
Observation 
1 Body weight Normal 1 Body weight Normally increased 
 
2 Assessments of posture Normal 2 Assessments 
of posture 
Normal 
3 Signs of Convulsion 
Limb paralysis 
Normal 3 Signs of 
Convulsion 
Limb 
paralysis 
Absence of sign (-) 
4 Body tone Normal 4 Body tone Normal 
5 Lacrimation Normal 5 Lacrimation Absence 
6 Salivation Normal 6 Salivation Absence 
7 Change in skin color No significant 
color change 
7 Change in 
skin color 
No significant color 
change 
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8 Piloerection Normal 8 Piloerection Normal 
9 Defecation Normal 
 
9 Defecation Normal 
 
10 Sensitivity response Normal 10 Sensitivity 
response 
Normal 
11 Locomotion Normal 11 Locomotion Normal 
12 Muscle gripness Normal 12 Muscle 
gripness 
Normal 
13 Rearing Mild 13 Rearing Mild 
14 Urination Normal 14 Urination Normal 
Table no 23: observational study results of Eladhi chooranam 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming 5. Gripping 6. Touch 
Response 7. Decreased Motor Activity 8. Tremors 9. Convulsions 10. Muscle Spasm 
11. Catatonia 12. Muscle relaxant 13. Hypnosis 14. Analgesia 15. Lacrimation 16. 
Exophthalmos 17. Diarrhoea 18. Writhing 19. Respiration 20. Mortality. 
(+ Present, - Absent)  
 
N
o 
Dose mg/kg 1 2 3 4 5 6 7 8 9 
1
0 
1
1 
1
2 
1
3 
1
4 
1
5 
1
6 
1
7 
1
8 
1
9 
2
0 
1. Control + - - + - + - - - - - - - - - - - - + - 
2. 
2000mg/
kg 
 
+ - - + - + - - - - - - - - - - - - + - 
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Table no 24: Body weight (g) changes of rats exposed to Eladhi Chooranam 
 
 
N.S- Not Significant, **(p >0.01), *(p >0.05), n = 12 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
 
Table no 25: Water intake (ml/day) of Wistar albino rats group exposed to 
Eladhi chooranam 
 
N.S- Not Significant, **(p >0.01), *(p >0.05), n = 10  values are mean ± S.D 
(One-way ANOVA followed by Dunnett’s test) 
 
 
 
DOSE 
 
DAYS 
1 7 14 
CONTROL 270.1±65.70 272.7±09.71 270.06±2.10 
High DOSE 260.3±4.44 261.4±7.12 260.2±6.05 
P value (P*) NS NS NS 
DOSE 
 
DAYS 
1 6 14 
CONTROL 60±1.62 62±1.10 69.1±1.04 
High DOSE 69.5±1.04 69.5±2.07 71.8±2.04 
P value (P*) NS NS NS 
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Table no 26: Food intake (gm/day) of Wistar albino rats group exposed to Eladhi 
chooranam:                
 
 
 
 
 
 
 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10  values are mean ±         
S.D (One way ANOVA followed by Dunnett’s test) 
Discussion: 
 In the acute toxicity study, the rats were treated with different concentration of 
Eladhi chooranam from the range of 5mg/kg to 2000mg/kg. 
 The test groups compared to the controls when observed during14 days of the 
acute toxicity experimental period. This dose level of EC did not produce 
signs of toxicity, behavioural changes, Body weight and mortality.  
 No significant alterations were observed in food and water intake. 
 These results showed that a single oral dose of the extract showed no mortality 
of these rats even under higher dosage levels indicating the high margin of 
safety of this extract.  
 In acute toxicity test, based on OECD 423 the trial drug Eladhi chooranam 
was found to be nontoxic at the dose level of 2000mg/kg body weight. 
 
 
 
 
 
DOSE 
 
DAYS 
1 7 14 
CONTROL 62.4±1.54 62.2±1.62 62.7±4.06 
High DOSE 64.0±2.24 64.4±2.10 64.6±2.70 
P value (P*) NS NS NS 
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RESULTS OF SUB-ACUTE ORAL TOXICITY 28 DAYS REPEATED DOSE 
STUDY IN RATS 
Table no 27: Body weight (g) changes of rats exposed to Eladhi  Chooranam 
 
NS- Not Significant, **(p > 0.01),*(p >0.05), n = 12 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
 
Table no 28: Water intake (ml/day) of Wistar albino rats group exposed to Eladhi 
chooranam 
 
 
N.S- Not Significant, **(p > 0.01),  *(p >0.05), n = 12  values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
DOSE 
 
DAYS 
1 7 14 21 28 
CONTROL 180.6±3.62 181.4±4.14 183.7±9.61 184.6±3.03 185.7±1.31 
LOW DOSE 183.2±1.14 182.7±3.64 180.4±8.32 180.1±4.66 178.4±3.76 
MID DOSE 186.6±1.64 184.3±2.74 182.4±8.32 181.1±3.16* 177.7±3.82** 
HIGH DOSE 184.4±6.74 182.6±2.12 178.6±2.36* 172.2±4.78 174.12±2.39** 
P value (P*) NS NS NS NS NS 
DOSE 
 
DAYS 
1 6 14 21 28 
CONTROL 61.5±8.95 61.5±6.23 62.7±6.23 62.6±8.196 62.9±3.96 
LOW DOSE 68.5±3.12 68.4±4.12 68.8±3.24 68.2±1.28 68.7±4.23 
MID DOSE 69.7±1.23 69.3±2.11** 69.1±1.13 69.4±1.21** 69.4±1.14 
HIGH DOSE 63.1±1.12 63.2±2.23** 63.4±1.23 63.2±2.33* 63.4±1.25** 
P value (P*) NS NS NS NS NS 
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Table no 28: Food intake (gm/day) of Wistar albino rats group exposed to Eladhi 
chooranam 
        N.S- Not Significant, **(p >0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
Table No 30: Haematological parameters of Wister albino rats group exposed to 
Eladhi chooranam 
N.S- Not Significant, **(p >0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
DOSE 
 
DAYS 
2 7 23 22 28 
CONTROL 37.12±5.37 38.5±3.22 39.5±3.37 39.5±3.37 40±3.12 
LOW DOSE 39.7±2.98 39.3±2.32 39.1±7.28* 40.4±2.92 41.6±1.62* 
MID DOSE 40.2±1.25 40.2±1.20 41.2±2.15 41.4±1.28 41.7±2.44** 
HIGH DOSE 41.3±1.24 41.6±1.24 42.7±2.66* 42.6±1.20* 42.1±3.12** 
P value (P*) NS NS NS NS NS 
Category Control Low dose Mid dose High dose 
P value 
(p)* 
Haemoglobin(g/dl) 13.8±0.88 13.90±1.16 15.14±0.66 16.28±1.16 N.S 
Total WBC (×10
3   
l) 11.91±0.59 11.85±1.23 11.08±1.21 11.11±2.27 N.S 
Neutrophils (%) 33.65±0.06 33.3±1.24 32.11±2.16 33.20±1.10 N.S 
Lymphocyte (%) 70.24±1.48 70.02±1.12 70.20±1.16 70.10±1.26 N.S 
Monocyte (%) 0.86±0.07 0.58±0.19 0.72±0.13 0.71±0.60 N.S 
Eosinohil(%) 0.54±0.09 0.54±0.12 0.62±0.16 0.72±0.04 N.S 
Platelets cells10
3
/µl 687.17±8.76 678.71±9.16 675.18±2.20 672.16±3.74 N.S 
Total RBC 10
6
/µl 7.99±0.12 7.79±1.57 7.62±0.19 7.05±0.12 N.S 
PCV% 37.79±0.6 37.35±1.23 37.98±1.18 36.82±2.14 N.S 
MCHC g/dL 33.6±2.23 33.29±1.19 33.18±1.12 34.03±1.14 N.S 
MCV fL(µm
3
) 49.07±3.64 49.28±8.12 49.20±1.24 49.2±1.94 N.S 
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 Table no 31: Biochemical Parameters of Wistar albino rats group exposed to 
Eladhi chooranam  
       
NS- Not Significant, **(p >0.01), * (p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test 
 
Table no 32:Renal function test of of Wistar albino rats group exposed to Eladhi 
chooranam       
 
 
NS- Not Significant, **(p >0.01), * (p >0.05) , n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
 
BIOCHEMICAL 
PARAMETERS 
CONTROL LOW DOSE 
MID 
DOSE 
HIGH 
DOSE 
P Value 
(p)* 
GLUCOSE (R) (mg/dl) 74.45±13.4 74.16±1.24 74.26±1.22 75.12±9.60 N.S 
T.CHOLOSTEROL(mg/dl) 115.26±1.83 113.45±1.13 
108.42±1.7
8 
99.22±1.93 N.S 
TRIGLY(mg/dl) 46.35±1.48 44.22±1.28 42.58±1.80 39.66±1.13* N.S 
LDL 73.8±2.43 70.24±3.14 68.14±1.24 65.64±4.12 NS 
VLDL 15.2±2.44 15.82±1.14 15.44±2.14 15.24±4.16 NS 
HDL 26.66±6.88 26.16±1.24 26.68±2.16 26.78±1.12 NS 
Albumin(g/dL) 
3.3±0.17 3.23±0.22 2.48±2.02 
3.14±3.16 
NS 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
P Value 
(p)* 
UREA (mg/dl) 13.35±0.99 14.81±1.26 16.26±1.18 21.28±3.12 N.S 
CREATININE(mg/dl) 0.58±0.08 0.48±0.06 0.72±0.14 0.74±0.12 N.S 
BUN(mg/dL) 15.12±0.10 15.12±0.28 16.28±0.14 16.90±1.22 N.S 
URIC ACID(mg/dl) 5.37±0.35 5.11±0.43 6.72±2.15 6.28±0.14 NS 
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Table 33: Liver Function Test of of Wistar albino rats group exposed to Eladhi 
chooranam       
 
 NS- Not Significant, **(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
Results: 
 Observations 
Overall observations were similar in both sex rats. 
Clinical signs of toxicity 
No clinical signs of toxicity were observed. 
Mortality 
No mortality was observed after 28 days repeated dose administration of EC. 
All animals survived to study termination period. 
Body weight 
The result of the body weight of rats exposed to control and the trial drug of 
different dose groups exhibited overall mild weight loss throughout the dosing period 
of 28 days. The quantity of food taken by the animals from different dose groups and 
the control is comparably normal.  
Food and water consumption 
No effect of treatment was noted. 
Physiological activities 
 No changes in the general behavior 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
P Value 
(p)* 
T BILIRUBIN(mg/dl). 0.05±0.07 0.05±0.16 0.06±0.18 0.05±0.15 N.S 
SGOT/AST(U/L) 114.95±1.39 115.15±2.11 116.21±1.23 116.55±1.23 N.S 
SGPT/ALT(U/L) 71.23±1.28 72.91±1.59 72.34±2.18 71.32±1.28 N.S 
ALP(U/L) 146.25±8.77 144.2±6.27 149.16±4.17* 153.3±4.25* NS 
T.PROTEIN(g/dL) 6.32±0.38 6.48±1.34 6.52±0.23 6.53±1.26 N.S 
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Blood analysis 
a. Hematology 
No treatment related effects were observed. 
b. Biological parameters 
No treatment related effects were observed. 
c. Histological examination 
Histological examination of organs did not show any pathological changes. 
Repeated Oral Toxicity Discussion: 
 The repeated 28 days’ oral toxicity studies of EC showed that the drug did not 
produce any toxicity signs in wistar albino rats. Daily administrations of EC at 
different doses 20mg/kg, 200mg/kg, 400mg/kg for 28 days were tolerated by 
the rats without any mortality and morbidity indicates the drug tolerance. 
 No physical changes were observed throughout the dosing period. 
 No significant changes were observed in the values of different parameters 
studied when compared with controls and the values obtained were within 
normal biological and laboratory limits. 
 No significant changes in Red blood cells (RBC) white blood cell (WBC), 
packed cell volume (PCV) in all the treated groups as compared to respective 
control groups. 
 Hence the Poly herbal formulation of EC can be considered to be safe drug for 
prolonged duration use as revealed by toxicological studies. 
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HISTOPATHOLOGY  
   Control group                                                                  EC 400 mg 
                   Kidney                                                                       Kidney 
 
                                 
 
 
 
 
    
                           Liver                                                  Liver                                                                        
 
 
 
 
 
       
 
 
Spleen          Spleen                                                                                                                                   
  
 
    
                                                          
 
 
 
 
Fig no: 10 
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Discussion 
The above slides show the histopathology studies of sub-acute toxicity. There 
is no toxicological abnormality seen in the vital organs after administration of the test 
drug Eladhi chooranam. Thus the safety of the drug is revealed, so that it can be 
administered for long time without any side effects 
PHARMACOLOGICAL STUDY 
 
ANTI-HYPERTENSIVE ACTIVITY 
SHR (9 weeks old) and age-matched Wistar rats male weighing 250±20g, Rats 
were kept in a room temperature controlled room (25 ° C), with 12 h dark and 12 h 
artificial illumination daily (7:00— 19:00). Food and water were available ad libitum. 
Systolic blood pressure (SBP) and heart rate measurement of SH rats was carried out 
using tail-cuff method plethysmography (LE 5001 Pressure Meter). 
GROUPING 
The animals were divided into following groups: 
Table No 34: Grouping of animals 
 
The drug Eladhi chooranam was administered orally and once daily for 4 weeks. 
 
 
 
 
 
 
 
 
Group I Control untreated group which received normal saline. 
Group II Received Verapamil 12.5 mg/kg b.w 
Group III ELADHI CHOORANAM  200mg/kg b.w 
Group IV ELADHI CHOORANAM  400mg/kg b.w 
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Table no 35: Effect on Systolic Blood Pressure (SBP) of Eladhi Chooranam on 
various treatment groups on SH-rats 
 
 
Values represent mean ± SEM of 6 experiments.* P< 0.05; ** P< 0.01; *** P 
< 0.001, treatment versus control group 
C
on
tr
ol
EC
M
20
0m
g
EC
M
40
0m
g
Ve
ra
pa
m
il
0
50
100
150
200
250
Groups
S
B
P
m
m
H
g
Control
ECM200mg
ECM400mg
Verapamil
Systolic Blood Pressure (SBP) of ECM
 
Chart no.1. Effect of Systolic Blood Pressure (SBP) of EC on various treatment 
groups on SH-rats at 28
th
 day 
 
S:NO 
Treatment 
group 
SBP 
Initial 
 
7
th 
 day 
 
14
th
 day 
 
21
st 
 day 
 
28
th
 day 
1. Control 220.3±4.15 210.4±6.46 208.2±2.86 202.6±2.64 200.3±8.65 
2. EC 200 210.4±6.86 196.8±6.82 170.2±4.62 161.8±8.42 
152.4±2.14
** 
3. EC 400 190.8±6.24 182.2±6.24 165.2±4.82 150.8±8.26 
126.2±3.12
*** 
4. 
Verapamil 
hydrochlorid
e  
12.5mg/kgb.
w 
182.6±4.28 170.2±2.46 158.6±4.86 142.4±6.40 
110.2±2.08
*** 
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Table no 36: Effect on Heart rate (HR) of Eladhi chooranam various treatment 
groups on SH-rats 
 
Values represent mean ± SEM of 6 experiments.* P< 0.05; ** P˂ 0.01; *** P 
< 0.001, treatment versus control group 
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Chart no.2. Effect on Heart rate (HR) of Eladhi Chooranam on various treatment 
groups on SH-rats at 28
th
 day 
S:NO 
Treatment 
group 
HR 
beats/minut
e 
Initial 
 
 
7
th
 day 
 
 
14
th  
day 
 
 
21
st
 day 
 
 
28
th
 day 
1. Control 498.2±5.81 496.6±2.86 493.7±4.01 491.8±8.1
0 
490.2±6.43 
2. EC 200 490.6±2.84 480.8±4.21 462.2±4.01 446.2±4.8
2 
436.4±1.02
** 
3. EC 400 482.6±4.81 455.21±8.2
4 
421.8±4.46 390.8±4.8
1 
367.2±2.21
*** 
4. 
Verapamil 
hydrochloride  
12.5mg/kgb.w 
470.6±6.21 438.6±8.24 
 
400.8±8.62 364.68±2.
1 
320.1±1.14
*** 
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Discussion: 
 The systolic blood pressure and heart rate were recorded in the conscious 
animals in non-invasive tail cuff method. 
 The results reveals that the EC exhibits antihypertensive effect in the form 
of significant lower in systolic blood pressure and heart rate after 
continued administration for 7 days. 
 Heart rate was also decreased significantly in comparison to control 
 The reduction in systolic blood pressure was measured and tabulated. The 
readings were compared with control group 
 The systolic blood pressure on 7th day in group III treated with EC 
400m/kg body weight showed moderate reduction in Systolic blood 
pressure compared with 7
th
 day of control 
 But the reduction of Systolic blood pressure measured on 21st day of EC 
400mg /kg body weight treated group showed significant reduction of 
Systolic blood pressure compared with 21
st
 day of control group 
persistence highly significant antihypertensive effect was noticed even 
after cessation of dosing 7 days earlier. This suggests absence of rebound 
phenomenon after withdrawal of the test drug EC which an advantage in 
the therapy of hypertension. 
 The Siddha Polyherbal formulation EC, according to their traditional uses 
and phytochemical constituents based on their therapeutic value leads to 
discovery of newer and safer alternative drug and herbal medicines having 
a protective role in cardiovascular diseases.
 
DIURETIC ACTIVITY 
Lipschitz et al was employed this method for the assessment of diuretic 
activity. The animals were deprived of food and water for 16tn hours prior to the 
experiment. Before oral administration of test drug the animals were dosed with 
25ml/kg body weight of normal saline. The total volume of was measured. The 
urinary pH, sodium, potassium and chloride also determined. The diuretic activity 
result of EC was derived and tabulated below. 
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Table no 37: Effect on urine volume of Eladhi  Chooranam  on various treatment 
groups on SH-rats 
 
Diuretic index = volume of test group/volume of control group 
Values are expressed in mean±SD; .* P< 0.05; ** P˂ 0.01;  
***P<0.001, compared with control group (Kruskall Wallis and Mann Whitney test) 
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Chart no3: Effect on urine volume of Eladhi  Chooranam on various treatment 
groups on SH-rats 
S:NO 
Groups  Treatment Urine 
volume/100gm/2
4hr 
Diuretic index               
(24hr interval) 
1. I Control  7.12±1.04 - 
2. II Furosemide  14.02±3.02 2.01 
3. III ECM  200mg/kg 7.21±2.06 2.01 
4. IV ECM  400mg/kg 10.82±1.14 2.52 
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Table no 38: Effect on urine electrolyte excretion of Eladhi Chooranam on 
various treatment groups on SH-rats  
 
 
 
 
 
 
 
 
 
Values are expressed in mean±SEM; .* P< 0.01; ** P˂ 0.001; *** P < 
0.001,    compared with control group (Kruskall Wallis and Mann Whitney test) 
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Chart no 4: Effect on urine electrolyte excretion of Eladhi  Chooranam on 
various treatment groups on SH-rats 
Groups 
Na
+
 
m.mol/L 
K
+
 
m.mol/L 
Cl 
– 
m.mol/L 
Na/K 
Control 116±2.20 53.2±1.10 89.2±2.14 2.06 
Frusemide 138±1.10 92.2±2.20 129.2±2.04 2.32 
ECM 
200mg/kg 
175.1±1.02 100.1±1.04 150.2±1.14 1.62 
ECM 
400mg/kg 
159.03±1.02 76.62±2.31 112.3±2.31 1.02 
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Discussion: 
 The results of diuretic activity of EC showed marked increase in urine volume 
 There was no evidence of dehydration of animals. Animals were observed 
normal at 5 hours and 24 hours interval. 
 The standard diuretic Frusemide significantly increased in urine output when 
compared to normal 
 The test drug EC at 200mg/kg b.w, 400mg/kg b.w doses, showed statistically 
significant increase in the volume of urine with a dose dependent manner 
 There is a significant change in the pH level of urine 
 Excretion of Na+, Cl- followed by similar pattern. Chloride excretion highly 
significant with two doses. 
 The diuretic activity of EC, 5 hours after its administration was manifested in 
the form of an increase in urinary volume, which was highly significant with 
200mg/kg b.w, 400mg/kg b.w doses at 5 hours urine analysis 
 Analysis of 24 hours post dosing urine sample revealed similar results with 
regards to urinary volume, sodium, chloride and potassium are observed in 5
th
 
hour sample. That indicates a continuation of diuretic effect of EC upto 24 
hours 
 An herbal preparation usually contains many active components (flavanoids, 
alkaloids, Phenols etc.)  
 The phyto chemical analysis of EC shows significant presence of these 
compounds which either alone or in combination is responsible for the 
diuretic activity 
 The diuretic study result of EC clearly indicates, that possesses potential 
diuretic activity on SH-rats and diuretic agents plays an important role in 
decreasing high blood pressure by decreasing plasma volume and also 
reducing cardiac work load and the oxygen demand 
[107] [108]
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ANTI-OXIDANT STUDY (In-Vitro) 
 Antioxidants are substances that can prevent or slow down to the damage to 
cells caused by free radicals, unstable molecules that the body produces as a 
reaction to environmental and other pressures. They are sometimes called 
"free-radical scavengers." 
 Antioxidants are said to help neutralize free radicals in our bodies, and this is 
thought to enhance the overall health. 
 Antioxidants can protect against the cell damage that free radicals cause, 
known as oxidative stress. 
Free radicals and their chemical reactions: 
 A free radical can be defined as any molecular species capable of independent 
existence that contains an unpaired electron in an atomic orbital. The presence 
of an unpaired electron results in certain common properties that are shared by 
most radicals.  
 Radicals are weakly attracted to a magnetic field and are said to be 
paramagnetic. Many radicals are highly reactive and can either donate an 
electron to or extract an electron from other molecules, therefore behaving as 
oxidants. As a result of this high reactivity, most radicals have a very short 
half-life (10
−6
 seconds or less) in biological systems, although some species 
may survive for much longer. 
 Oxidative stress has been linked to heart disease, cancer, arthritis, stroke, 
respiratory diseases, immune deficiency, emphysema, Parkinson's disease, and 
other inflammatory or ischemic conditions. 
Antioxidant action in Hypertension: 
          During hypertension, our body went at the condition of oxidative stress. In this 
oxidative stress condition, oxygen radicals such as superoxide anion, hydroxyl 
radicals and peroxyl radicals are produced. These oxygen radicals are reactive oxygen 
species and they can lead to oxidative damage to cellular components such as 
proteins, lipids, and DNA. These free radicals are reactive molecules involved in 
many of the physiological process such as atherosclerosis, hypertension and ischemic 
heart disease. These oxygen free radicals formed during the oxidative stress are 
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resulting in the disturbances of vasodilators system; particularly degrading of nitric 
oxide which is mainly due to the endothelial dysfunction are the effects of 
hypertension
 [109]
.  
Result: 
Table no 39: DPPH assay on Eladhi chooranam 
 
*µg/ml: microgram per millilitre. Drug:  EC (1.25-20µg/µl). Standard: 
Ascorbic acid (10mg/ml DMSO)  
Chart no 5.1: DPPH assay on Eladhi Chooranam (Percentage of Inhibition) 
  
 
 
 
 
 
 
 
 
 
 
Chart no 5.2  DPPH assay on Eladhi Chooranam (Absorbance) 
Sample 
concentration 
(µg/ml) 
Absorbance 
Percentage of Inhibition 
Drug Standard 
Drug 
EC 
Standard 
Ascorbic 
acid 
Control 0.3547 1.7983 0 0.00 
12.5 1.0452 1.4044 15.10 21.90 
25 0.9818 1.0782 25.44 40.04 
50 0.5049 0.7121 52.23 60.40 
100 0.1663 0.2921 72.12 83.75 
200 0.0827 0.0692 83.68 96.15 
12.5 25 50 100 200
Drug EC 15.1 25.44 52.23 72.12 83.68
Standard 21.9 40.04 60.4 83.75 96.15
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Discussion on Antioxidant activity in DPPH assay: 
DPPH assay were used for the determination of Anti-oxidant activity of the 
different extracts. DPPH stable free radical method is an easy, rapid and sensitive way 
to survey the antioxidant activity of EC extract.  The antioxidant molecules can 
quench DPPH free radicals by providing hydrogen atom or by electron donation and a 
colourless stable molecule 1, 1 diphenyl-2- picrylhydrazil is formed and as a result of 
which the absorbance at 517nm of the solution is decreased.  
In the present study, the EC extract was analysed able to decolorize DPPH and 
the free radical scavenging activity. Ascorbic acid (10 mg/ ml DMSO) was used as a 
reference and result was expressed as the percentage decrease in absorbance.  In the 
present study, the extract of EC was found to possess concentration dependent 
scavenging activity on DPPH radicals.  
The values of DPPH free radical scavenging activity of the EC extract was 
given in (Table) expressed in the percentage. The extract of EC was found to 
possess concentration dependent scavenging activity on DPPH radicals. The 
extract of EC showed the highest DPPH scavenging activity (83.68%) at 
200µg/ml and the lowest percentage of inhibition (15.10%) at 12.5µg/ml. Ascorbic 
acid (Standard) showed highest percentage of inhibition (96.15%) at 200µg/ml 
and the lowest percentage of inhibition (21.90%) at 12.5µg/ml. This indicated that 
12.5 25 50 100 200
Drug EC 1.0452 0.9818 0.5049 0.1663 0.0827
Standard 1.4044 1.0782 0.7121 0.2921 0.0692
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% of inhibition increased within increase in concentration of both the standard and 
EC extract.  The EC extract has more or less equal DPPH scavenging activity when 
compared to the standard. From the present study, it was concluded that the 
EC extract has a marked antioxidant activity at higher concentrations. Antioxidant 
compounds are highly present in plants and have protective effects against 
diseases without reducing their therapeutic efficacy 
[110]
. So, using of natural 
antioxidant as a protective strategy against cardiovascular related problems
 [111]
. 
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                                        6. CONCLUSION 
 
The intention of this study is to provide a solution for the above need. Eladhi 
Chooranam was chosen from the Siddha literature as a trial drug “Sarabenthirar 
Vaithya Muraigal ” written by Dr.S.Venkatarajan (L.I.M) to validate the safety and 
its efficacy of drug to treating Anti-Hypertensive, Diuretic and anti-oxidant activity in 
Spontaneously Hypertensive  Rat (SHR) model.  
The trail drug was subjected various studies through which the efficacy of the 
drug is proved.  
The ingredients of the test drug was identified and authenticated by the Siddha 
experts. The drug was prepared as per the procedure and subjected to various studies 
to reveal its potency and effectiveness against the disease. 
The procedure for drug preparation and its techniques for standardization revealed 
GMP. The trial drug EC has satisfied all parameters of testing protocol for 
Chooranam which was assigned by AYUSH. 
Various analysis such as organoleptic character, physicochemical, phytochemical, 
biochemical analysis, anti-microbial activity, instrumental analysis were done. 
The organoleptic characters of the drug Eladhi chooranam showed the Brown 
colour, Bitter amd Sweet in taste which might be responsible for the activity 
mentioned earlier. The fineness of the chooranam represents easy absorption and 
better availability of the drug. 
The physical character of EC shows good solubility and the pH of the trial drug is 
4.24 that indicate the better absorption and effectiveness.  
Phytochemical screening test showed the presence of Alkaloids, Glycosides, 
Saponin, Phenol, flavonoids, Protein, Diterpines, Gum and Mucilage may be 
responsible for the anti-hypertensive activity.  
The HPLC finger prints were made and it shows 14 peaks. In which the two major 
peaks denotes presence of phytochemicals and Rf value of the trial drug supports the 
better standardization of the trial drug EC.  
Biochemical analysis showed the presence of potassium, calcium, magnesium, 
ammonium, sodium, chloride and zinc. The potassium, calcium, magnesium, sodium, 
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chloride supports anti-hypertensive activity and it has a potent anti-oxidant activity of 
the trial drug (EC)). 
The anti-microbial activity of trial drug was also considered for its potential. 
The instrumental analysis FTIR showed the 9 peak values present, in which the 
functional groups are alcohol, Phenols, Alkenes, Aldehyde, Carbonyls, Nitro 
compounds, Carboxylic acids, Esters, Ethers, Amine, Aromatic groups responsible for 
its activity.  
SEM picture described its morphology and the particle size. EC which is prepared 
biologically contains micro particles to enhance the pharmacological action at the 
target site. 
 The results of ICPMS shows  that there is a mild presence of  the heavy metals 
like As, Cd, Hg, Pb and  were below detectable level. This reveals the safety of the 
drug in treating Hypertension. 
  Toxicological study of both acute and sub-acute toxicity study were carried out 
in animal model Wistar albino rat according to the OECD guidelines. The test drug 
showed no acute toxicity as there was no mortality seen and then 28 days of repeated 
oral toxicity were done in 28days to show that the trail drug doesn’t produce any toxic 
effect while it was given for long period.  
The mortality, functional observations, hematological and biochemical 
investigations were done. There was no significant change seen in the normal values. 
Thus the toxicological study of the test drug greatly establishes the safety and gives 
the justification for long time administration. 
The pharmacological study was carried out in the animal model Spontaneously 
Hypertensive Rats. Three activities were seen in the drug Eladhi Chooranam. The 
activities were  
 
 Anti-hypertensive activity 
 Diuretic activity  
 Anti-Oxidant activity [IN-VITRO] 
Anti-hypertensive activity was carried out in Spontaneously Hypertensive Rats. 
The trial drug Eladhi Chooranam-400mg/kg b.w showed significant decrease in 
systolic blood pressure and heart rate. Thus this activity reveals the effect of the drug 
against Hypertension. 
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Diuretic activity of Eladhi chooranam-400mg/kg b.w shows statistically increase 
in urine volume, excretion of urine electrolytes and there is no evidence of 
dehydration of animals were found, observed normal at 5 hours and 24 hours interval. 
Anti-oxidant activity of the test drug Eladhi Chooranam was carried out in in-
vitro model. The EC extract has more or less equal DPPH scavenging activity when 
compared to the standard (ascorbic acid). From the present study, it was 
concluded that the EC extract has a marked antioxidant activity at higher 
concentrations. 
Factors like safety, efficacy, long self like, bio-availability, presence of significant 
elements; minerals favoring the activity justify the main perspective of this study. 
Thus by scrutinizing all the above mentioned factors it is concluded that the trial 
drug Eladhi Chooranam is a safe and a potent anti-hypertensive drug. It also 
possesses diuretic and anti-oxidant activity which supports the effective treatment for 
managing Hypertension and its complications. 
Modern medicine has its own limit in treating Hypertension and controls high 
blood pressure. Whereas in treating the disease with this trial drug it has a synergistic 
effect of controlling high blood pressure, diuretic effect and also has anti-oxidant 
property. Thus it brings a complete treatment for Hypertension and its complications. 
From the study Eladhi Chooranam has been proven as a safety and best drug for 
treating hypertension.   
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7. SUMMARY 
The trial drug Eladhi chooranam was selected from the siddha literature 
“Sarabenthirar Vaithya Muraigal” authored by Dr.S.Venkatarajan (L.I.M) for Anti-
hypertensive, Diuretic, Anti-oxidant activities. The dissertation started with an 
introduction explaining about the siddha concept, prevalence of hypertension and role of 
the test drug in treating hypertension, 
 The test drug was prepared properly by the given procedure. All the ingredients were 
identified and authenticated by the experts. 
 Review of literature in various categories was carried out. Siddha aspect, botanical 
aspect and pharmaceutical review disclosed about the drug and the disease. 
Pharmacological review was done to establish the methodologies. 
 The drug was subjected to analysis such as organoleptic characters, physicochemical, 
phytochemical, biochemical and also instrumental analysis which provided the key 
ingredients present in the drug thus it accounts the efficacy of the drug 
 Toxicological study was made according to OECD guidelines comprising both acute 
and sub-acute toxicity study. It showed the safety of the drug which attributes its 
utility in long time administration. 
 Pharmacological study was done. It revealed the Anti-hypertensive, Diuretic and 
Anti-oxidant activity (in –vitro model) of Eladhi chooranam in spontaneously 
hypertensive rat model.  
 Results and discussion gives the necessary justifications to prove the potency of the 
drug. 
 Conclusion gives a compiled form of the study and explains the synergistic effect of 
all the key ingredients and activities that supports the study.  
 Thus, the Polyherbal formulation Eladhi chooranam is validated for its safety and 
efficacy for treating hypertension and it would be a one of the drugs of choice. 
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8. FUTURE SCOPE 
 The trial drug Eladhi Chooranam has its own potency in treating Hypertension in 
Spontaneously Hypertensive rat model, which has been established in this study. 
However, the mechanism of action by which Eladhi Chooranam produced its effect on 
decreasing the systolic blood pressure and heart rate in experimental animals need to be 
evaluated in a scientific manner using specific experimental animal models and also 
multi-center clinical trials are required to understand the exact molecular mechanisms of 
action. So, it could be used worldwide in treatment of Hypertension. 
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Medical College, Arumbakkam, Chennai-600 106, were identified as: 
 
Ingredients of Eladhi Chooranam: 
 
1. Elettaria cardamomum (Elakkai) 
 
2. Nelumbo nucifera (Thamarai poovithaz) 
 
3. Nymphea nouchali (Alli poovithaz) 
 
4. Cyperus rotendus (Korai kizhangu) 
 
5. Glycyrrhiza glabra (Athimathuram) 
 
6. Syzygium aromaticum (Kirambu) 
 
7. Ziziphus marutiania (Ilanthai kottai paruppu) 
 
8. Dryobalanops aromatica (Pahai karpooram) 
 
9. Oryza sativa (Nerpori) 
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